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Abstract 
Background: Early and adequate resuscitation is of importance for the outcome of trauma victims. 
The traumatized tissue is a source of bleeding from damaged vessels and leakage of plasma, resulting 
in reduction of intravascular blood volume. Cascade systems are activated leading to increased 
capillary permeability and tissue perfusion. Small volume resuscitation with 4 ml/kg of body weight 
of hypertonic saline ± colloid has been shown to reverse severe haemorrhagic shock by im proving 
both macro- and microcirculation. The aim of the present study was to evaluate the metabolic and 
circulatory effects of small volume hypertonic saline ± colloid resuscitation of haemorrhage in 
primary hypertension (paper I) and tissue ischaemia (paper II, III), and in paper IV even the 
extension of the myocardial damage. 
Methods: Anaesthetized spontaneously hypertensive rats-SHR (I), Wistar rats (II), and pigs (III, 
IV) were studied. I: SHR were bled 30% of the blood volume and treated with either hypertonic 
glucose 42.3% (HG), hypertonic saline 7.5% (HS), or normal saline 0.9% (NS). II: Anterogradely 
perfused isolated rat hearts were paced to a heart rate of 325 beats per min and preload kept at 7.5 mm 
Hg while the afterload was altered from 80 to 25 mm Hg to induce ischaemia for 27 min. The hearts 
were exposed to either ischaemia alone, or ischaemia followed by repeated HS treatment, or repeated 
HS without preceding ischaemia. Ill: The efficacy of hypertonic fluid therapy on central 
haemodynamics, leg blood flow, and skeletal muscle metabolism at reperfusion after subtotal bilateral 
limb ischaemia for 240 mins was studied. Haemodynamic and metabolic alterations were followed 
for 180 min after reflow. IV: A midsternal thoracotomy was performed, and the left anterior 
descending coronary artery (LAD) occluded for 45 min. After a reperfusion period of 240 min 
biopsies from the ischaemic area were taken, the hearts excised, subjected to a staining procedure, 
and the left ventricle was sliced for assessment of the size of infarcted area and area at risk. In paper 
III and IV 4 ml/kg body weight of either NS, HS, or HS+6% dextran 70 (HSD) were administered 
and the infusion was started 5 min prior to reperfusion and continued during a 10 min period. 
Results: I: All fluid regimens increased mean artenal pressure and prolonged posthaemorrhagic 
survival, NS more than HG (mean survival: NS 363 min; HS 170 min; HG 146 min; nontreated 
controls 60 min). II: HS administration during cardiac ischaemia induced a transient myocardial 
depression as also seen in nonischaemic hearts following HS. III: The haemodynamic support prior 
to and following reflow after limb ischaemia was more efficient for HS and HSD than for NS. 
Lactate clearance and restitution of high energy phosphagen levels in skeletal muscle were faster and 
more pronounced for HS and HSD. IV: HS depressed cardiac performance at reperfusion while 
HSD improved hemodynamics and myocardial contractility. HS or HSD failed to reduce the 
myocardial damage. 
Conclusions: I: Small-volume HS seems superior to HG. An equal load of sodium given as NS is 
more effective for resuscitation after haemorrhage than HS in SHR. The sodium load, therefore, 
seemed more beneficial than hyperomolarity per se. II: Systemic rather than direct myocardial effects 
may be responsible for previously reported beneficial haemodynamic effects of HS in shock 
treatment. Ill: Small-volume HS, especially in combination with 6% dextran 70, will ef fectively 
reverse limb ischaemia-induced haemodynamic and tissue metabolic disturbances. IV: Administra­
tion of HSD but not HS improves haemodynamics and myocardial performance at reperfusion after 
45 min of myoc ardial ischaemia. Neither HS or HSD reduced or increased the myocardial damage. 
Key words: Haemorrhage, small-volume resuscitation, hypertonic glucose, hypertonic saline, 
sodium chloride, osmolality, dextran 70, spontaneous hypertension, mortality, cardiac function, 
coronary flow, myocardial ischaemia, myocardial metabolism, acute limb ischaemia! 
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Abbreviations 
AAR Area at risk 
ADP Adenosine diphosphate 
AMP Adenosine monophosphate 
ANOVA Analysis of variance 
ATP Adenosine triphosphate 
avD02 Arterial-venous oxygen content difference 
BE Base excess 
BSA Body surface area 
b.w. Body weight 
CF Coronary flow 
CI Cardiac index 
CO Cardiac output 
CrP Creatine phosphate 
CVP Central venous pressure 
DO2 Oxygen delivery 
dP/dt Rate of increase in left ventricular pressure 
dP/'ci t MAX Maximum rate of increase in left ventricular pressure 
ECG Electrocardiogram 
ECF Extracellular fluid 
EDTA Ethylenediamine tetraacetate 
EVF Erythrocyte volume fraction; haematocrit 
HG Hypertonic glucose 
HR Heart rate 
HS Hypertonic saline 
HSD Hypertonic saline 7.5% + 6% Dextran 70 
IBP Iliac artery blood pressure 
LA Efflux Cardiac lactate efflux 
LAD Left anterior descending coronary artery 
LV Left ventricle 
LVP Left ventricular pressure 
LVEDP Left Ventricular end diastolic pressure 
LVSW1 Left ventricular stroke work index 
MAoP Mean aortic pressure 
MAP Mean arterial pressure 
MPAP Mean pulmonaiy artery pressure 
MV02 Myocardial oxygen consumption 
NS Normal saline 0.9% 
02-Extr. Oxygen extraction 
Pa02 Arterial oxygen tension 
PaC02 Arterial carbon dioxide tension 
PEEP Positive end expiratory pressure 
PCV Packed cell volume; haematocrit 
PCWP Pulmonary capillary wedge pressure 
PLSD (Fisher's) protected least significant difference 
PVR Pulmonary vascular resistance 
RPP Rate pressure product 
Sa02 Arterial oxygen saturation 
S-ASAT Serum-aminotransferase 
S-CK Serum-creatine kinase 
S-CK-MB Serum-creatine isoenzyme MB 
S-TNT Serum-Troponin-T 
SEM Standard error of the mean 
SHR Spontaneously hypertensive rat 
sv Stroke volume 
SVI Stroke volume index 
Sv02 Mixed venous oxygen saturation 
SVR Systemic vascular resistance 
TEB Thoracic electrical bioimpedance 
TFI Thoracic fluid index 
TTC Triphenyltetrazolium chloride 
VO2 Oxygen consumption 
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1. Introduction 
Fluid Resuscitation of Shock and Tissue 
Ischaemia 
In the past years it has become obvious that a key factor 
rendering patients to develop multiple systems organ failure (MSOF) 
after shock and ischaemia is the persistence of impaired 
microcirculation with tissue hypoxia and deterioration of cellular 
function.1 Prehospital, perioperative and intensive care related efforts 
aim at the reduction of trauma deaths by efficient resuscitation from 
hypovoiaemia and rapid reversal of the systemic hypotension and 
restoration of oxygen delivery to the tissues.1 Although the initial 
treatment of trauma patients is focused on measures to eliminate life-
threatening airway blocking, support of ventilation and oxygen delivery 
(DO2). fluid therapy is an important component of the resuscitation. 
The optimal composition and amount of fluid for resuscitation has 
been discussed in decades and factors such as haemostasis, tissue 
oxygenation, cell metabolism, haemodynamies, and microvascular 
blood flow have been considered in detail. Quite often a crystalloid-
colloid controversy in the treatment of trauma patients has been 
focused on.2 However, more and more interest has during the last 
decade been focused on the potential value of small-volume (4 ml/kg 
body weight) resuscitation with hypertonic (7.5%) sodium chloride 
(2.400 mOsm/kg).3'4 
Definition of Small Volume HS Resuscitation 
Hypertonic Resuscitation is by Kramer in the Hypertonic 
Resuscitation Website defined as - "the infusion of hypertonic or 
hyperosmotic fluid to improve cardiovascular function in an animal or 
man suffering from shock or circulatory dysfunction".5 
Small Volume Resuscitation is usually given as a bolus 
infusion of about 10% of the estimated blood volume deficit or 4 ml/kg 
b.w. of hypertonic (7.5%) or hypertonic-hyperoncotic saline solution 
within 2-5 min through a peripheral vein for primary resuscitation from 
severe hypovoiaemia generally seen after trauma and haemorrhage.1-6 
10 Waagstein L.M. Small Volume Resuscitation 
Nakayama et al6 introduced the term "small-volume 
resuscitation" in 1984 when they were able to show that a bolus 
injection given over 60 s of HS 7,5% equal to 10% of shed blood volume 
rapidly normalized blood pressure and cardiac output in haemorrhaged 
conscious sheep. These improvements were however transient. 
Historical Background 
Hypertonic solutions have been used since the first part of this 
century (Penfleld7 1919; Read et al.81961; Baue et al.9 1967; 
Wildenthal et al.10 1969; McNamara et al.11-12 1970, 1972; Wolf13  
1971) and among the described effects positive inotropy and 
vasodilation were considered beneficial. Possible disadvantages due to a 
hypotensive effect, accentuated by increasing the rate of injection as 
well as by raising the concentration (5% NaCI, 12,5% urea in saline) 
was reported by Read et al8. It was also noted in several of the above 
reports that the beneficial effects were transient in the treatment of 
haemorrhagic hypotension. 
In 1980 Velasco et al14 reported on the administration of highly 
hypertonic saline (HS 7.5%, 2400 mOsm/1) to dogs subjected to 
haemorrhagic shock. The infused volume was very small (4 ml/kg body 
weight), and equal to 10% of the shed blood volume. HS rapidly 
restored arterial pressure and cardiac output to base-line values and 
resulted in 100% survival. The control group resuscitated with normal 
saline (0.9%) had no survivors. This study was followed by several 
others and the concept of "small volume resuscitation" was 
constituted.6 In addition to resuscitation of haemorrhagic shock there 
are several studies which show the efficacy of HS in the treatment of 
burn injury, head trauma, endotoxin shock, and in ischaemia-
reperfusion situations as summarized in recent reviews by Rocha e 
Silva3 and Kramer et al.4 
The first study investigating the use of HS in combination with a 
colloid (addition of 6% dextran 70) was described by Smith et al15 
(1985) and it was followed within the next 5 year period by a number of 
experimental and clinical studies Maningas1617 (1986,1989), Kreimeier 
et al18 (1987), Holcroft et al19 (1987), Velasco et al20'21 (1987, 1989), 
Kramer et al22 (1989), Wade et al23>24 (1989, 1990). In the resuscitation 
of haemorrhaged animals, these studies confirmed that the 
combination of HS and dextran (HSD) was superior to HS alone. HSD 
induced a higher cardiac output, slightly better and more sustained 
plasma volume expansion, and increased survival rates. 
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The first clinical study on HS in the treatment of shock 
appeared in 1980 and was carried out by DeFelippe et al.25 In the study 
12 patients in refractory hypovolaemic shock were treated with small 
volumes of HS (maximum 200 ml) and a significant pressor response 
with recovery of consciousness and urine output was seen in 11 of the 
patients. Since then the clinical efficacy of HS and USD in the 
treatment of shock and trauma patients has been assessed in detail in 
a number of randomized double blind studies. Holcroft et al19 (1987), 
and Younes et al26 (1992) used prehospital infusion of 2,50 ml of HSD 
in trauma patients and reported that the treatment improved the 
clinical outcome. Since then a number of studies have been performed 
as recently summarized by Kramer et al4 (1997). In a meta-analysis of 
all available studies Wade et a!27 (1997) found that treatment with 
HSD resulted in a 3.6% higher discharge survival rate than treatment 
with standard fluid regimens. 
Physiological Mechanisms of HS 
The different main effects of HS treatment are summarized in 
Table 1 (Haljamäe et al, 1995).28 
Table 1. Effects of HS treatment. 
Fluid redistribution 
• increased intravascular volume 
-haemodilution 
-reduced blood viscosity 
-increased venous return 
-increased preload 
-increased cardiac output 
Vasodilation 
• reduced afterload 
-improved regional blood flow 
-reduced cardiac work 
Cellular de swelling 
-improved capillary blood flow 
-reduced tissue oedema 
Direct cellular membrane ejfects 
• central sympathetic activation 
• cellular functional alterations 
12 Waagstein L.M. Small Volume Resuscitation 
Hs induces a rapid mobilization of fluid from the extra- and 
intracellular compartments into the intravascular compartment 
resulting in a dynamic support of central haemodynamies.29 This fluid 
redistribution, caused by the osmotic HS gradient, is similar to the 
physiological transcapillary fluid mobilization that is induced by the 
hyperglycaemic response to shock and trauma.30 The ability to increase 
blood glucose and maintain hyperglycaemia has been related to 
increased survival after haemorrhage. However, the circulatory effect 
induced by 7.5% HS is more pronounced. In spite of the fact that an 
initial physiological glucose-osmotic transcapillary refill has already 
taken place as part of the early physiological response to shock- or 
trauma there will be an additional pronounced increase in plasma 
volume in response to infusion of HS solutions.29 
An important functional role of concentrated sodium ions has 
been demonstrated31-32 and thereby the relative importance of 
osmolality as compared to ionic composition of hypertonic solutions in 
shock treatment. Electrolyte solutions based on cations other than 
sodium or anions other than chloride do not reverse haemorrhagic 
shock and improve survival rates as efficiently as hypertonic sodium 
chloride.31 Hypertonic glucose has e.g. a less pronounced intravascular 
volume expanding and arterial blood pressure supporting effect than 
HS. A greater volume expanding effect from HS as compared to 
hypertonic glucose may be explained by a distribution of sodium ions 
mainly within the extracellular space, while glucose is also taken up 
and metabolized by tissue cells. Hypertonic glucose seems in addition 
to cause an increased lactic acid load due to enhancement of anaerobic 
glucose metabolism.32 The importance of the sodium ion as compared 
to osmolality per se for the efficacy of hypertonic fluid therapy in shock 
is consequently well documented and a high plasma sodium level seems 
essential for survival.28-32 
The HS induced haemodilution caused by the dynamic fluid 
redistribution offers haemorheological advantages seen as improved 
blood flow through the terminal vascular bed and an enhanced venous 
return.33 There is an efficient restitution of organ perfusion following 
HS infusion, especially if a hypertonic-hyperoncotic fluid combination 
rather than HS alone is chosen.34 A deswelling of blood cells and 
vascular endothelial cells will occur following infusion of HS in 
addition to the direct vasodilatoiy effects of HS.35 
Introduction 13 
Hs solutions in the treatment of hypovolaemic conditions 
improve cardiac output A14-19 31 .36-39 Although results from studies of 
intact animals suggest that myocardial contractility may be increased 
by HS614-40'41 there is still only limited information available on the 
direct myocardial effects of HS on shock- and ischaemia-induced 
cardiac dysfunction. A number of the available studies indicate that the 
direct effects of HS on myocardial performance may be depressant 
rather than stimulatory.8'42"45 There are data suggesting that the 
contractility is decreased as well as blood flow in the ischaemic 
myocardium by HS infusion, while in the normal myocardium both 
coronary blood flow and contractility increase.46 This could lead to 
worsening of ischaemic injury, which may be deleterious in hearts with 
impaired contractile function caused by ischaemia.46 However, the 
extension of myocardial damage following HS or HSD administration 
after acute myocardial infarction has so far not been reported. 
Effects of the Dextran Component 
Since the volume supporting effect of HS is transient, the use of 
colloids in addition to HS has been evaluated. It was early established 
that the usual combination of 7.5% hypertonic saline-6% dextran 70 
(HSD) of 4ml/kg body weight in the resuscitation of haemorrhagic 
hypotension was efficient. In the first 10-30 minutes after infusion HS 
alone47 and HSD expands plasma volume 3-4 times the infused 
volume, but only HSD sustains the plasma volume expansion after 3 
hours.4 This is to compare with isotonic 0.9% saline which is a poor 
volume expander as only one-third of the infused volume remains in 
circulation after 2 hours.4 The plasma volume expansion effect induced 
by HSD results in improved haemodynamic function and survival in 
otherwise lethal animal models of haemorrhage.16-21-23 
Nolte et al demonstrate that HSD (bolus infusion of 7.2 % 
NaCl/10% dextran 60) effectively attenuates postischaemic 
microvascular disturbances in striated muscle elicited by ischaemia-
reperfusion, presumably through reduction of postischaemic leucocyte-
endothelium interaction (i.e. reduces leucocyte rolling and sticking in 
the microcirculation). HSD also effectively attenuates macromolecular 
leakage and reduces capillary endothelial swelling as assessed by 
measurements of c apillary diameters. HS alone was significantly less 
efficient in protecting from post-ischaemic leucocyte-endothelial 
interaction.48 
mnMSïWiSliki 
• 
si fe'Ê ïas ïSifllSilfSSS: 
iSSiii 
ilfipfip«'' 
•«•\ - - u\ '<  ^-•- • £v -- •- , 
••• ' ••• • 
§j®|l#!lf 
$SÊà§ÉÈêÉtâêê:i 
HISMlBfiSlÄliJS 
iliiiiii 
;. ;~;;Â«Î53;»;#«.WÂ SiHSHS 
"*•' " ,: • : 
, 
' 
mmmmm iSSSSÄll 
mmmissm 
SÄti® SiffStitt 
Aims oj the Present Study 15 
2. Aims of t he Present 
S t u d y  
The alms of the present study were experimentally to evaluate 
the circulatory and metabolic effects of: 
I Small volume hypertonic saline as compared to non-ionic 
hypertonic solution (glucose) in the resuscitation of haemorrhage 
in animals with reduced shock tolerance (spontaneously 
hypertensive rats - SHR) (paper!). 
II Hypertonic saline on the non-ischaemic and ischaemic 
myocardium by the use of an isolated working rat heart 
model (paper II), 
IH Small volume hypertonic saline ± colloid as compared to isotonic 
saline treatment of acute limb ischaemia (simulated aortic saddle 
embolism in pigs) (paper III). 
IV Small volume hypertonic saline ± dextran treatment of acute 
regional myocardial ischaemia (LAD occlusion in pigs) (paper IV). 
16 Waag stein L. M. Small Volume Resuscitation 
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3. Materials  and Methods 
Experimental Animals 
All experiments were approved by the Animal Ethics Committee 
of the University of Göteborg and conducted in accordance with the 
National Institute of Health guidelines for the use of experimental 
animals. 
The investigations were performed in: 
Paper I: Thirtytwo 5-6 months old male Spontaneously 
Hypertensive rats (SHR) weighing 330-430 g. 
Paper II: Thirtytwo 3-4 months old Wistar rats of 
either sex, weighing 300-430 g. 
Paper III: Twentyfour crossbreeding pigs 
(Swedish landrace, Yorkshire, and Pigham) 
of either sex, weighing 26-50 kg. 
Paper IV: Thirtyfour crossbreeding male, not castrated 
pigs (Swedish landrace, Yorkshire, and 
Hampshire) of three months of age, 
weighing 18-28 kg. 
The rats had free access to food and water until the start of the 
experiments (I, II). The pigs were fasted for 15 h prior to the 
experimental procedures but had free access to water until the 
experimental day (III, IV). 
All pigs were premedicated with pethidine hydrochloride (Petidin®) 50 
mg (III) and 40 mg plus 1 mg of atropine (Atropin®) (IV) intramuscularly 
30 min before transfer to the operating room. 
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Anaesthesia and Surgical Procedures 
Four different haemorrhagic shock or ischaemia associated 
experimental conditions were studied. 
Paper I: 
Anaesthesia was achieved by an intraperitoneal dose of the 
short-acting barbiturate, pentobarbital sodium (60 mg/kg body weight), 
and if needed additional doses (9-12 mg/kg) were given during the 
experiment. A polyethylene catheter (PE 50) was inserted into one of 
the femoral arteries for bleeding, and blood sampling, as well as 
recording of mean arterial pressure and heart rate. The catheter was 
flushed with 250 units of heparin to prevent clotting. One jugular vein 
was cannulated for intravenous infusions. The animals were placed in 
the lateral position to keep free airways and breathed room air. 
Paper II: 
The animals were anaesthetised with a single intraperitoneally 
administered dose of an ultra-short-acting barbiturate, methohexital 
(Brietal®) 75-100 mg/kg b.w. Heparin 1000 IU/kg b.w. was at the same 
time administered in order to reduce the risk of intravascular 
thrombotic events due to activation of the coagulation system during 
the preparative surgical procedure for the isolation of the heart. A 
thoracotomy was rapidly performed and the heart was excised and put 
into ice-cold saline, which stopped the functional activity within a few 
seconds. The aorta, which was transected about 4-5 mm above the 
aortic valves, was immediately mounted on a steel cannula and 
retrograde perfusion of the coronary arteries started usually within 30 
sec from the time of excision. During the retrograde perfusion the left 
atrium was connected via one of the pulmonary veins to an angled steel 
cannula, while the other pulmonary veins were ligated (Figure 1). 
Antegrade perfusion was started by clamping the tube from the pre-
perfusion reservoir and unclamping the tube connected to the left 
atrium. The preparative procedure for antegrade perfusion has 
previously been described in detail.49 
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The perfusate was an oxygenated (95% 02/5% CO2) Krefas-
Henseleit bicarbonate buffer containing (mmol/1): NaCl 118, KCl 4.7, 
CaCl2 2.5, MgSQ4 1.2, KH2PO4 1.2, NalICO;} 25, di-NaEDTA 0.5, and 
glucose 14. The temperature of the perfusate was kept at 37° C. 
The antegrade perfusion apparatus consisted of a 130 cm long 
oxygenation chamber from which the perfusate passed via a micropore 
filter and duplicate bubble traps to the left atrium. The preload of the 
left atrium could be adjusted by changing the height of the bubble trap 
immediately proximal to the heart and the pressure level was measured 
and recorded via a side-tube connected to a Statham 23 DC transducer 
and a Grass polygraph recorder (model 7 D, Grass Instrument Co. 
Quincy, MA, USA). The aortic pressure against which the heart pumped 
was set at the desired level by means of a Starling resistor49»50 and the 
pressure was measured and recorded just above the aortic valves via a 
thin steel cannula and PE-10 tubing (Statham 23 DC transducer, 
Grass polygraph recorder). A Windkessel effect on the aortic outflow was 
achieved by attaching the aortic cannula to a 8 mm wide and 40 mm 
long Penrose drain rubber tube interconnected to a 2 ml syringe 
containing 1 ml of air and 1 ml of saline (Figure 1 ). 
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Figure 1. Schematic illustration of the experimental setup for antegradely 
perfused hearts. Left atrial pressure and aortic pressure could be altered 
independently. The hearts were electrically paced. Aortic flow (AF) and coronary 
flow (CF) w ere collected and intermittently weighed in separate funnels by 
means of a force transducer and balloons in the funnels driven by a magnetic 
switch and an air pressure system. Oxygen tension was continuously 
measured in the coronary venous effluent. (Figure re drawn from Sahlman L et 
al49 with permission from Anesthesiology). 
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Paper III: 
Anaesthesia was induced with ketamine hydrochloride (Ketalar®) 
1000 mg given intramuscularly. An ear vein was then cannulated and 
methomidate (Hypnodil®) 100 mg and azaperone (Stresnil®) 40 mg were 
administered intravenously. Anaesthesia was maintained with 
supplementary doses of methomidate and azaperone when needed and a 
basal fluid infusion of normal saline (0.9 % NaCl) was administered at 
a rate of 30 ml/kg/24 h. A prophylactic dose of the antibiotic, 
Cloxacillinsodium (Ekvacillin®, Astra, Södertälje, Sweden) 1000 mg 
was administered intravenously prior to the surgical procedure to 
prevent wound infection. The animals were placed on their right side 
and breathing spontaneously. In this position a vascular graft was 
inserted as previously described.51 A left lumbar incision was made 
followed by minor retroperitoneal dissection for visualisation of the 
lateral aortic wall. A p artially occluding vascular clamp was applied on 
the visible lateral aspect of t he aorta approximately 5 cm proximal to 
the aortic bifurcation. An 8 mm preclotted dacron vascular graft was 
then sutured end-to-side to the aorta, using 4/0 Prolene. Care was 
taken to avoid damage to periarterial vessels, nerves, and lymphatics 
during this procedure. The outer end of t he vascular graft was closed 
with a ligature and placed subcutaneously. The wound was closed and 
infiltrated with bupivacaine hydrochloride 5 mg/ml, adrenaline 5/^g/ml 
(Marcain® adrenalin) 10 ml for postoperative pain relief and the 
animals were allowed to recover. 
Approximately one week later the acute experiment took place. 
The pre-experimental handling of the animals was identical to that at 
the insertion of the vascular graft. Anaesthesia was maintained and the 
basic needs for fluid requirement satisfied by i.v. infusion of 500 ml 
0.9% NaCl containing 3000 mg of methomidate, 800 mg of azaperone, 
and 100 mg of pethidine. The infusion rate was set at 30 ml/kg/24 h. 
Supplementary doses of methomidate and azaperone were given when 
needed during the experiment. After tracheostomy via a midline neck 
incision, the animals were mechanically ventilated with 30% oxygen in 
room air using a Servo ventilator 900 (Elema Schönander, Sweden). The 
ventilated minute volume was set to keep PaCC>2 at 4.5-5.5 kPa. An in­
dwelling catheter was inserted suprapubically into the urinary bladder. 
A catheter was placed into the superior caval vein via the left external 
jugular vein for measurements of the central venous pressure and for 
fluid infusions. 
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A triple-channel balloon catheter (Pruitt venous thrombectomy 
catheter 7 F. Ideas for Medicine, INC. Tampa, FL, US) with one lumen 
proximal and the other distal to the balloon was introduced into the 
distal abdominal aorta via the previously inserted graft. 
The balloon was placed immediately above the aortic bifurcation and 
inflated in order to induce acute occlusion of the distal aorta (Figure 2). 
Figure 2. Schematic illustration of the experimental model for acute distal 
aortic occlusion. ABP = Aortic blood pressure channel, inner end. APC = Aortic 
blood pressure channel, outer end. B = balloon. FB = Filling channel of the 
balloon catheter. EH = end hole of the balloon catheter. IBP = channel for iliac 
blood pressure. (Figure modified from Jivegård L et al51 with permission from 
European Journal of Surgery). 
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Paper IV: 
The induction and maintenance of a naesthesia as well a s the 
basal fluid administration were similar as in paper III with the 
exception of lower induction doses of methomidate (50 mg), and 
azaperone (12 mg). The procedures for tracheostomy and ventilation 
were also similar as in paper III. 
A venous line was established via a vein in the right hind limb to 
administer the treatment fluids. An arterial line was placed into the left 
femoral artery for blood sampling and blood pressure monitoring and a 
fiberoptic five-lumen pulmonary artery catheter (OPTICAT®, 5.5 F. 
Abbot Laboratories North Chicago, U.S.) was placed into the pulmonary 
artery via the right external jugular vein and used with the Oximetrix® 
3 System SO2/CO Computer, Abbot Laboratories North Chicago, U.S.) 
that displays venous oxygen saturation and thermodilution cardiac 
output curves, and calculates, from standard formulae, several 
hemodynamic variables. The pressures were recorded via pressure 
transducers (Dispo-sense® Peter von Berg GmbH, München, Germany) 
and a monitor (Model 78342, Hewlett Packard, MA, U.S.). A high fidelity 
pressure measuring catheter 8 F consisting of two sensors with one 
sensor in the left ventricle and the other one in the aorta, was placed 
into the right carotid artery and retrogradely inserted into the left 
ventricle (LV) for the measurement of LV sy stolic pressure, LV end -
diastolic pressure, +dP/dt and aortic pressure. The catheter was 
connected to two pressure interfaces (SENTRON® Pressure 
Measurement System. Cordis Corporation, Miami, FL, U.S.). ECG and 
all pressures were recorded by a-model 7 D, Grass polygraph recorder 
(Grass Instrument Co. Quincy, MA, U.S.). During the experiment all 
catheters were continuously flushed with heparin 5000 IU in 500 ml of 
NaCl 0.9% to prevent clotting. Animals showing signs of d isease (e.g. 
pneumonia or pericarditis) when chest was opened, iatrogenic 
complications during the surgical procedure, depressed left ventricular 
function, or ventricular fibrillation resistant to defibrillation during 
coronary occlusion or at reperfusion were excluded from further 
evaluation. 
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Surgical Procedure and Induction of Myocardial 
Ischaemia 
The model for the surgical procedure and myocardial infarct size 
quantification used in this study has previously been described.52 Ten 
min after the catheterizations were finished baseline data were 
collected. Thereafter a midsternaJ thoracotomy was performed and a 5 
mmHg positive end-expiratory pressure (PEEP) was established. 
The pericardial sac was opened and a 1 cm section of the left 
anterior descending artery (LAD) dissected free from the epicardium just 
distal to its first diagonal branch and topical lidocaine (2%) was 
applied to prevent vasospasm during LAD isolation. A snare was placed 
under the isolated LAD an d this was used for a slow removal of the 
occlusion to prevent reperfusion arrythmias. Heparin (1000 IU) was 
administered intravenously to prevent clotting. A stabilization period of 
30 min was allowed before pre - LAD-occlu s ion data were collected. 
The LAD w as then occluded for 45 min using a microaneurysm 
clip and the occlusion was confirmed by observation of regional 
cyanosis and ventricular systolic bulging distal to the LAD-occlusion in 
the corresponding area of the myocardium. Reperfusion after 45 min of 
occlusion was established by removing the clip and confirmed by 
gradual (< 2 min) disappearance of the cyanotic ischaemic zone. Prior 
to the occlusion and reperfusion i.v. injection of Ketalar® 25-75 mg 
was given to reduce stress and the risk of ventricular fibrillation. 
Measurements and Recordings 
Paper I: 
Arterial blood pressure and heart rate were continuously 
recorded from one of the femoral arteries by a transducer (Gould P 23 1 
D) and recorded on a recorder (Grass model 7 D Polygraph Grass 
Instrument Co. Quincy, MA). Rectal temperature was monitored and 
the rats were warmed with a heating pad when the temperature fell 
below 36° C. 
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Paper II:  
Left atrial pressure (LAP), m ean aortic pressure (MAP), h eart rate 
(HR), aortic flow (AF), coronary flow (CF), and PO2 of the coronary 
venous effluent were continuously recorded (Grass model 7 D Polygraph 
Grass Instrument Co. Quincy. MA). Aortic flow was determined by 
collecting the outflow in a funnel placed on top of a transducer (FT 10, 
Grass Instruments) and weighing the outflow intermittently. The 
intermittent weighing and emptying of the funnel was regulated by an 
automatic, time-controlled, magnetic switch (collection and weighing 
time 6 sees; emptying time 4 sees). The coronaiy flow was allowed to 
flow freely onto a Clare PO2 electrode (Radiometer, Copenhagen, 
Denmark) before it was collected in a separate funnel and weighed 
(Figure 1). PO2 in the perfusate was measured intermittently. Cardiac 
output was calculated as the sum of the aortic and coronary flows. 
Stroke volume (SV) was calculated and expressed in fil/100 g of body 
weight. Myocardial oxygen extraction (%) was determined as: 
P02LA~P02V /P°2LA, 
and oxygen consumption (MVO2) was calculated as previously 
described.49 
Paper III:  
Aortic pressures above and below the occlusion were measured 
via the proximal and distal ports (Figure 2). Heparin (5000 IU) was 
administered intravenously. The proximal and distal aortic, and central 
venous pressures were measured and recorded continuously (pressure 
transducers dispo-sense® Peter von Berg GmbH, München, Germany; 
pressure monitor model 78342, Hewlett Packard, MA, US; recorder 
Multitrace 4, Lectromed, UK). An electrocardigram (ECG) was 
continuously monitored and recorded. 
A standard laser Doppler probe (Pf 108 d, Perimed, Sweden) was 
attached to the plantar surface of the right and left hind feet and 
connected to a Periflux PFld Laser Doppler Flowmeter (Perimed KB, 
Stockholm, Sweden) for assessment of skin blood flow.51 >53 
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Cardiodynamic data were obtained by thoracic electrical 
bioimpedance (TEB) measurements using a non-invasive continuous 
cardiac output monitor (NCCOM3-R6, Bomed Medical Manufacturing 
Ltd, Irvine, CA, US).54 The following data were obtained and registered: 
heart rate (HR), cardiac output (CO), s troke volume (SV), and thoracic 
fluid index (TFI). Calculated data were cardiac index (CI), stroke volume 
index (SVI), and systemic vascular resistance (SVR). 
Rectal temperature was measured intermittently and the animals were 
kept at a body temperature of about 38° C - 39° C by external heating. 
The weight of the animals was registered before and after the 
experiment to allow calculation of changes in body weight. 
Paper IV: 
The following data were measured and recorded throughout the 
experiment: Lead II electrocardiogram (ECG); body temperature (blood: 
Oximetrix® 3 System SO2/CO Computer Abbot Laboratories North 
Chicago, U.S) was registered intermittently and the animals were kept 
at about 37.5° C - 38,5° C by external heating; heart rate (HR); 
systolic, diastolic, and mean arterial pressure (MAP); sys tolic, and end-
diastolic LV pressure (LVEDP); +dP/dt; systolic, diastolic, and mean 
aortic pressure (MAoP); central venous pressure (CVP); systolic, 
diastolic, and mean pulmonary artery pressure (MPAP); pulmonary 
capillary wedge pressure (PCWP). Haemodynamic data for the 
calculations were based on the mean value of tr iplicate measurements 
at the end of the expiratory phase of the respiratory cycle. Rate 
pressure product (RPP = HR x MAP) and left ventricular stroke work 
index [LVSWI = SVI (MAP-PCWP) • 0.01 36] were calculated. 
From the Oximetrix® 3 System SO2/CO Computer and Printer the data 
were obtained for: body surface area (BSA): c ardiac output (CO) using 
the thermodilution technique (three accepted measurements at 
injection of 3 ml of 5% Glucose at room temperature); cardiac index 
(CI); mixed venous oxygen saturation (SvC>2); systemic vascular 
resistance (SVR); pulmonary vascular resistance (PVR); arterial-venous 
oxygen content difference (avD02); arterial oxygen content (Ca02); 
mixed venous oxygen content (Cv02); oxygen delivery (DO2); oxygen 
consumption (VO2). 
The following calculations were performed: Oxygen extraction (O2 -
extr.) = avD02/Ca02, and stroke volume index (SVI) = CI/HR. 
The animals were weighed before and after the end of the experiment to 
calculate changes in body weight. 
Matertals and Methods 27 
Laboratory Analyses 
Paper  I:  
For blood glucose and lactate determination perchloric acid (3M) 
was added to the blood samples (0.05 ml). After neutralization with 
KHCO3 (2M), the extracts were centrifuged (3000-g) and the 
supernatants analysed for glucose and lactate using an enzymic 
fluorometric assay. 
For determination of serum osmoles 0.3 ml of blood was sampled in a 
heparinized tube and analysed using a vapor osmometer (WESCOR 
5500 vapor pressure osmometer, Teknisk, Kjemisk a/b Wa Mo 
BERGEN, T0NSBERG, Norway).55 For determination of haematocrit, 
serum sodium, blood gas and acid-base state 0.25 ml was sampled in 1 
ml syringes prefilled with heparin lithium (CONCORD LABORATORIES 
LTD, Kent, England) and analysed with B G Electrolytes Analyzer (II 
BGE, Instrumentation Laboratoiy Spa, Milano, Italy). 
Paper  II:  
The coronary venous outflow was collected during 3 min periods 
(A-E; cf Figure 3) and the lactate concentration determined 
fluorometrically as previously described56 and the myocardial lactate 
efflux was calculated . The electrolyte content of the perfusate and the 
coronary venous outflow was analysed using a Radiometer KNA2 
analyzer (Copenhagen, Denmark). Osmolality of the coronary venous 
outflow was determined using a Cryomatic Osmometer Model 302 
(Advanced Instruments Inc., Needham Heights, MA). 
Paper  III:  
Arterial blood was sampled from the proximal channel of the 
aortic balloon catheter for analyses of haemoglobin (photometric 
method), haematocrit (microhaematocrit), and serum osmolality 
(freezing point depression, osmometer - Advanced Instruments Inc. 
Needham Heights, MA, US). Serum protein, sodium, potassium, and 
chlorides were analyzed with Kodak Ektachem Analyzer DT 60 and 
DTE-Modul (Eastman Kodak Company, NY, US) an d blood gases with a 
blood gas analyzer (ABL 500, Radiometer, Copenhagen, Denmark). 
28 Waagstein L.M. Small Volume Resuscitation 
Paper IV: 
Arterial blood was sampled from the femoral artery catheter for 
blood chemistry analyses (B G Electrolytes Analyzer (Il BGE, 
Instrumentation Laboratory Spa, Milano, Italy); haematocrit (Hct) 
(conductivity); haemoglobin (Hb) (estimated from measured 
haematocrit); sodium (Na+'; potassium (K+); ionized calcium (Ca++); 
hydrogen ion activity (pH); carbon dioxide partial pressure (pC02); 
oxygen partial pressure (pC>2); an d calculated parameters: base excess 
(BE): standard bicarbonate (SBC); and oxygen saturation (sC>2). 
Corrected at the animals body temperature are pH, pCC>2 and pC>2. 
Serum chlorides (CI"), blood glucose, and total protein were analysed 
with Kodak Ektachem Analyzer DT 60 and DTE-Modul (Eastman Kodak 
Company, NY, US), and serum osmolality (freezing point depression, 
osmometer - Advanced Instruments Inc. Needham Heights, MA, US). 
Blood lactate was analysed using an enzyme fluorometric assay. 
Serum Markers of Myocardial Necrosis 
Prior to. during, and after the induced myocardial ischaemia the 
following serum markers for myocardial necrosis were analyzed: serum-
aspartate aminotransferase (S-ASAT) and serum-creatine kinase (S-CK) 
determined by a spectrophotometrical assay; serum-creatine kinase 
isoenzyme MB (S-CK-MB) determined by immunological methodology 
(IMx CK-MB, Abbot Laboratories Diagnostic Division, Abbot Park, 
North Chicago, Illonois, USA); serum-Troponin-T (S-TNT) by 
immunometrical methodology (Enzymun-Test®, Boehringer-Mannheim, 
Germany). The S-CKMB/CK ratio was calculated. 
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Tissue Analyses 
Paper III: 
Skeletal Muscle Metabolites and Water Content 
In this study skeletal muscle biopsies were rapidly excised from 
the distal part of the gastrocnemic muscle and and immediately frozen 
in liquid nitrogen. The biopsies were homogenized in icecold perchloric 
acid (3 M), centrifuged (2000 g), a nd the extracts were neutralized with 
KHCO3 (2 M). Thereafter a second centrifugation was performed, 
separating the supernatant from the precipitate. The supernatants were 
used for fluorometric analyses of adenosine triphosphate (ATP), creatine 
phosphate (CrP), and lactate, and the pellets for determination of the 
protein content using previously described techniques.56 The metabolite 
levels were expressed as mnol/g protein. 
A second muscle biopsy was taken for determination of the water 
content by weighing prior to and after heat drying (desiccator at 70° C 
for 24 hours). The water content was calculated and expressed as a 
percentage. 
Paper IV: 
Myocardial Muscle Metabolites 
Cardiac muscle biopsies were rapidly excised from the damaged 
myocardial area at the end of the registered reperfusion period (R 240 
min) and immediately frozen in liquid nitrogen. The methods used for 
the analyses of the biopsies were similar as in paper III. The 
supernatants were used for fluorometric analyses of adenosine 
monophosphate (AMP), adenosine diphosphate (ADP), adenosine 
triphosphate (ATP), creatine phosphate (CrP), lactate, and glucose, and 
the pellets for determination of the protein content.56 The metabolite 
levels were expressed as //mol/g protein. 
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Myocardial Infarct Size Quantification 
At the end of the experiment the heart was rapidly excised and 
immersed in 37° C warm saline. Myocardial infarct size was quantified 
using Evan's blue (E. Merck, Darmstadt, Germany) and 
triphenyltetrazolium chloride (TTC, E. Merck, Darmstadt, Germany). 
Two catheters, connected to syringes containing Evan's blue (120 ml; 
0.4%), were inserted into the ostia of both coronary arteries, while the 
tip of another catheter, connected to a syringe containing TTC (60 ml; 
1% dissolved in 0.01 M Phosphate buffer at 37° C), was inserted into 
the LAD at the site of occlusion. The injection of TTC was started 
before and ending after the injection of Evan's blue. All fluids were 
injected rapidly from the syringes into the heart. The heart was placed 
in 37° C saline for 15 min, then 0,8-1.0 cm thick left ventricular slices 
were obtained. 
By this staining procedure, normal myocardium stained blue, 
area at risk stained red, while infarcted myocardium remained 
unstained. The slices were photographed (Hasselblad polaroid camera 
503 CX& 500 C/M, Victor Hasselblad AB, G öteborg, Sweden) (Figure 3) 
and the normal, at risk and infarcted areas were quantified by two 
independent individuals using a planimetric method (NIH Im age 1,54 
processing and analysis program for the Macintosh) and an area 
measurement protocol. The mean value of the areas measured by the 
two individuals were used. The coefficients of correlation between the 
measurements made by the two independent individuals were 0.91 for 
Area at Risk (AAR) % of left ventricle, and 0.97 for infarct size % of 
AAR, and 0.94 for infarct size % of left ventricle. 
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Figure 3. TTC- and Evan's blue-stained slices of the left ventricle 
in one pig. Blue area denotes normal myocardium, while viable 
myocardium (Area at Risk) is delineated with its bright red colour 
from the unstained (yellow-white) infarcted myocardium. 
1-6 show from the base to apex. 
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Experimental Procedures and Treatment 
Paper I: 
Acute blood loss of the SHR was Induced after a steady state 
period of at least 10 mln after the preparative procedures. 30% of t he 
calculated blood volume (6% of body weight) was withdrawn during a 20 
min period. After 5 min from the end of bleeding the animals were 
treated during a 10 min period according to three different fluid 
regimens, and a fourth group served as control (n=8 in each group). 
1. Hypertonic saline (HS 7.5%; 2,400 mOsm/1), 25% of shed 
blood volume = 4.5 ml/kg b.w. 
2. Hypertonic glucose (HG, 42.3%; 2,400 mOsm/1), 25% of 
shed blood volume = 4.5 ml/kg b.w. 
3. Normal (0.9%) saline (NS), to provide equal sodium load 
as in HS = 37.5 ml/kg b.w. (volume = 2.1 times shed blood 
volume). 
4. No treatment to a control group (C). 
Blood was sampled at steady state, after bleeding, and 30, 90, 
210, 330, 450, 510, 570, 630, and 690 min after treatment for 
determination of packed cell volume (PCV), blood glucose, blood lactate, 
serum sodium, serum osmoles, blood gas and acid-base state. At each 
sampling 0.8 ml of blood was drawn and the withdrawn volume was 
compensated for by infusion of an equal volume of isotonic saline. 
Sampling at steady state and immediately after bleeding was included 
in the shed blood volume. Spontaneous survival time after bleeding and 
treatment was followed. 
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Paper II:  
The function of i solated, atrial paced rat hearts (325 beats/min 
by a square-wave stimulator at a pulse duration of 4 msecs and 3 
volts), which were perfused by an antegrade technique49 at a filling 
pressure (left atrial pressure) of 7.5 mm Hg, was assessed in three 
different experimental groups, A 10 min stabilization was always 
allowed followed by a 3-min control period (Figure 4, period A). 
Ischaemia plus Hypertonic Saline Group (n = 12): 
Basal haemodynamic and metabolic data were collected during 
the initial 3-min control period (Figure 4, period A), at a mean aortic 
pressure of 80 mm Hg. Thereafter, myocardial ischaemia was induced by 
reducing mean aortic pressure during a 1-min period to 25 mm Hg and 
maintaining this low mean aortic pressure value for 27 rnins. After an 
initial 6-min period of ischaemia a 3-min data collection period (Figure 
4, period B) took place. Thereafter, heated (37° C) hypertonic saline 
(3%) was added to the perfusate to increase the sodium concentration 
to -150 mmol/1. After 6 mins had passed, there was a third 3-min data 
collection period (Figure 4, period C) fol lowed by a second addition of 
hypertonic saline to reach a sodium concentration of the perfusate of 
-160 mmol/1. Myocardial ischaemia was maintained for another 9-min 
period, including a 3-min period of data collection (Figure 4, period D). 
After the period of myocardial ischaemia mean aortic pressure was 
normalized during a 1-min period to 80 mm Hg. This mean aortic 
pressure value was maintained during an additional 9-min period, 
including a data collection period (Figure 4, period E). 
Control - Ischaemia Group (n = 8): 
Ischaemia was induced as in the ischaemia plus HS group but no 
HS was administered. 
Control - Hypertonic Saline Group (n = 12): 
In this group, there was no reduction of aortic pressure. However, 
HS was added to reach a sodium concentration that was similar to the 
sodium concentration of the ischaemia plus HS group. 
34 Waagstein L.M. Small Volume Resuscitation 
EXPERIMENTAI PROCEDURE 
STABILIZATION 
Min: 10 
MAP: 80 mmHg 
LAP: 7.S mmHg 
HR: 325 bpm 
MAP: 25 mmHg 
3 HI 
I 1 
I i 
I ! 
HS HS 
Figure 4. Schematic drawing of the experimental procedure (paper II). 
HS denotes addition of hypertonic saline. 
Paper III: 
After a stabilization period of 30 min baseline cardiodynamic and 
laser Doppler blood flow measurements were carried out and blood 
samples and muscle biopsies taken. Thereafter the balloon of the aortic 
catheter was inflated until pulsaltile back pressure disappeared and a 
subtotal ischaemia in both hind limbs achieved as evidenced by iliac 
back pressure and bilateral measurements of skin blood flow (laser 
Doppler). After 4 h of aortic occlusion the balloon was deflated and a 3 
h reperfusion period was studied. Thereafter the animals were killed 
with i.v. KCl. 
The animals were randomly assigned to three experimental fluid 
treatment groups. Fluid infusion was started 5 min prior to the release 
of t he aortic occlusion and continued for 5 min after the reperfusion, 
i.e. the infusion was completed within a 10 min period. The following 
fluid treatment regimens were studied: 
Group HS (n=8): 
Hypertonic saline (7.5%; 2 400 mOsm/1) 4 ml/kg b.w. 
Group HSD (n=8): 
Hypertonic saline (HS 7.5%; 2 400 mOsm/'l) in 
6% Dextran 70 (Pharmacia, Stockholm, Sweden), 4 ml/kg b.w. 
Group NS (n=8): 
Normal saline 0.9% 4 ml/kg b.w. 
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Cardiodynamic and laser Doppler data were registered 
- at baseline; 
- at 1, 5 and 20 mm after the aortic occlusion; 
- thereafter every 20 min during the occlusion; 
-  1 , 5 ,  15  a n d  3 0  m i n  a f t e r  d e f l a t i n g  t h e  b a l l o o n ;  
- thereafter every 30 min. 
Blood sampling and muscle biopsies were taken at baseline, 
after 220 min of ischaemia, 15 min after start of reperfusion 
(=10 min after the end of the treatment), and 180 min after 
start of reperfusion. 
Paper IV: 
The animals were randomly assigned to three experimental fluid 
treatment groups; 
Group HS: 
Hypertonic saline (7.5%; 2400 mOsm/kg), 4 ml/kg b.w. 
Group HSD: 
Hypertonic saline (HS 7.5%; in 6% Dextran 70 [Medisan 
Pharmaceuticals AB, Uppsala, Sweden]) 4 ml/kg b.w. 
Group NS: 
Normal saline 0.9%, 4 ml/kg b.w. 
Fluid infusion was started 5 min prior to the release of the LAD-
occlusion and continued for another 5 mins during reperfusion, i.e. the 
infusion was completed within a 10 min period. 
The treatment fluids were administered intravenously into a peripheral 
vein and the fluid volumes infused were regulated by the use of a 
volume pump (IVAC Mo d. No 561 MSS, IVAC Co rporation, San Diego, 
California, U.S.) 
Hemodynamic data were registered and blood chemistry 
analysed: 
- at 10 min after finishing the catheterizations 
- baseline values before surgery. 
- during a 30 min stabilisation period - at -30, -15, -5 min. 
- during LAD-occlusion at +5, +15, +30, +40, +45 min. 
- following reperfusion at 5, 15, 30, 60, 90, 120, 180, 240 min. 
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Blood sampling for serum markers of myocardial necrosis were 
obtained: 
- at 10 min after completing the catheterizations 
= baseline values before surgery. 
- during a 30 min stabilization period: -30 min, -5 min. 
- during LAD-occlusion: +40 min. 
- following reperfusion at 180 and 240 min. 
At each blood sampling the withdrawn volume was compensated by an 
infusion of an equal volume of normal saline (drawn from 500 ml of 
0.9% NaCl containing 5000 IU of he parin). 
Statistics 
Statistical comparisons between groups were performed with 
one-factor ANOVA with the Fisher's protected least significant 
difference (PLSD) comparative test (I, II, IV) and two-factor repeated 
measures ANOVA (I, III). 
When significant ANOVA, t he 2-tailed unpaired t-test (II) and the 
non-parametric analysis Mann-Whitney U-test (TV) was used to 
determine differences between two groups. In paper III the non-
parametric analysis of variance, Kruskal-Wallis test was used to test 
differences between three groups. When significant, the Mann-Whitney 
U-test was used for statistical comparison between two groups. The 2-
tailed student's paired t - test (I, II) and the non-parametric Wilcoxon's 
signed rank test (I, III, IV) was used to determine changes within a 
single group. Analysis of covariance was used to test for differences 
between groups when adjusted for baseline differences (II). R egression 
analysis was used for comparison of the results from the inter-
individual planimetric measurements for quantification of the infarct 
sizes and areas at risk (IV). 
In all studies data are presented as mean ± st andard error of the 
mean (mean+SEM) and p-values of less than 0.05 are considered 
significant (I-IV). 
The computer software used for statistical analysis was StatView 
SE+Graphics {Abacus Concepts, Inc., Berkeley, CA, USA). 
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4.  Resul ts  
Paper I 
Changes in Blood Chemistry to Acute Blood Loss in SHR 
Immediately after haemorrhage the glucose level had increased in 
the treatment groups (p < 0 .001) and control group (p < 0 .01). Serum 
osmolality had increased (p < 0.05) in the control and HG groups, while 
PCV had decreased (p < 0.001) from prehaemorrhagic values in all 
groups. At the end of b leeding the reduction of PCV was 12-15% in all 
groups. Lactate levels (p < 0.001) and pC>2 (NS- p < 0.001, C and HS- p < 
0.01, HG- p < 0.05) increased and base excess (C, HS, NS- p < 0.001, 
HG- p < 0.01) and pCO2 (C, HS, NS- p < 0.001, HG- p < 0,05) decreased 
similarly in all groups after bleeding. 
Changes in Blood Chemistry 30 and 90 minutes after 
Treatment of Acute Blood Loss in SHR 
At 30 mins after treatment PCV ha d been reduced from baseline 
levels by 20 % in controls, 22% with HS, 16% with HG, and 30 % with 
NS treatment. At 90 mins, haemodilution was of similar magnitude in 
HS- and NS-treated animals and greater than in the HG-treated 
animals (p < 0.05). Sodium levels were higher at 30 and 90 mins after 
HS treatment (p < 0.05) than in the other groups. Serum osmoles 
reached a maximum level of 310 ± 6.6 mOsm/kg water at 30 mins after 
HS (not significant vs other groups). At 30 mins, glucose levels were 
higher in the HG group [p < 0.05) than in the other groups. Ixictate 
levels were at 30 mins lower in the NS group than in the HG group (p < 
0.05), and after 90 mins lactate was lower in the HS and NS g roups 
than in the HG group (p < 0 .05). 30 mins after treatment pCO2 was 
higher (p < 0. 05) and the base excess lower (p < 0. 05) in the NS g roup 
than the other groups, and at 90 mins this difference persisted for the 
NS group in comparison with the HG g roup. No significant pH changes 
were seen in any of the groups throughout the experiment. 
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Hemodynamic Responses to Acute Blood Loss in SHR 
K rom prehaemorrhagic levels of a mean arterial pressure (MAP) of 
175 ± 3 mm Hg and heart rate (HR) of 343 ± 8 beats per minute (bpm), 
MAP reached a level of 43 ± 3 mm Hg after haemorrhage of 30% of the 
calculated blood volume. In response to bleeding, increases as well as 
reductions of HR were seen in an inconsistent pattern. There were no 
differences in MAP and HR between groups before treatment. 
Hemodynamic Responses after Treatment of Acute Blood 
Loss in SHR 
Changes during 20 mins from start of treatment 
The MAP r esponse during the first 20-min period after start of 
treatment is detailed and compared with untreated animals in Figure 5. 
All treatment regimens raised MAP significantly (p < 0.001) vs the 
untreated control group (C). MAPs were higher after normal saline (NS) 
(p < 0 .001) and hypertonic saline (HS) (p < 0. 01) than after hypertonic 
glucose (HG), while there were no significant differences between HS 
and NS. 
Figure 5 .  MAP dur ing 20 min after haemorrhage and ten min period of 
treatment with either hypertonic saline (HS), hypertonic glucose (HG), a nd 
normal saline (NS), and the control group (C). 
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Changes during 160 mins from start of haemorrhage. 
MAP and HR changes during 160 min period from start of 
haemorrhage are shown in the treatment groups in Figure 6. The 
control group is excluded in the figure because of its short suivi val 
time. Mortality in the treatment groups toward the end of this period 
were observed, and only 4 rats treated with HS, 5 with HG, a nd 7 with 
NS were alive. 
MAP was higher after HS- (p < 0 .05) and NS- (p < 0 .001) than after 
HG- treatment, while there was no significant difference between HS 
and NS. 
Hr increased more in rats treated with HG (p < 0.0 5) and HS (p < 0.01) 
than in animals treated with NS. 
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Times Until Death 
No animals died before treatment was completed. The number of 
animals alive after the treatment period is shown in Figure 7. Mean 
times until death were 363 min (range 45-740 min) after treatment with 
NS, 170 min (32-455 min) after HS, 146 min (range 67-296 min) after 
HG, and 60 min (range 22-150 min) in untreated animals. Time until 
death was longer in all the treatment groups than in controls (NS vs C 
p < 0 .01; HS and HG vs C p < 0. 05), and longer for NS than for HG 
treated SHR (p < 0. 05). No statistical significance in the HS group vs 
HG and NS. 
8 
HS 
H3 
NS 6 
4 
2 
0 
0 200 400 600 800 min 
Figure 7. Number of animals alive after the treatment period. 
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Paper II 
In this experimental study in ischaemic and nonischaemic 
isolated working rat hearts, the effects of hypertonic saline (HS) on 
myocardial function and metabolism were examined. Hypertonic saline 
administration to the perfusate caused an additional transient 
depression of the ischaemic hearts, and in the nonischaemic hearts a 
transient myocardial-depressant effect was also seen. 
Initial concentrations (during period A) of so dium, potassium, 
and osmolality of the venous coronary effluent are shown in Table 2. 
Coronary flow (CF), stroke volume (SV), myocardial oxygen 
consumption (MVO2). oxy gen extraction (02-extr.), and lactate efflux 
in Table3. 
Myocardial Effects of Ischaemia 
Control-Ischaemia group and Ischaemia plus Hypertonic Saline group 
The myocardial ischaemia ensuing by the reduction of MAP to 25 
mm Hg resulted in pronounced disturbances of cardiac function and 
metabolism. CF, SV, MVO2, C>2-extraction and lactate efflux values 
were significantly (p < 0.05 to 0.001) altered compared with the 
nonischaemic group (control-hypertonic saline group; control period B 
through D; Figures 8 and 9, Table 3). 
Sodium, Potassium, and Osmolality of the Perfusate after 
Hypertonic Saline 
Ischaemia Plus Hypertonic Saline group and Control-Hypertonic Saline 
group 
Administration of hypertonic saline resulted in a similar 
increase of sodium concentration in the perfusate in the ischaemia 
plus hypertonic saline and the control-hypertonic saline groups, while 
the potassium concentration remained unchanged and similar in all 
three groups. The osmolality increased by -30 mOsm/kg after 
hypertonic saline in both groups (Table 2). 
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Figure 8. Effects of repeated administration of hypertonic saline (HS) on 
coronary flow, stroke volume, myocardial oxygen consumption, and myocardial 
oxygen extraction. Open circles, control hearts receiving ischaemia; solid circles, 
hearts receiving ischaemia and hypertonic saline; open triangles, control hearts 
receiving hypertonic saline. Values are mean ± SEM. Statistically significant 
differences are denoted for effects of hypertonic saline: * p < 0.05; ** p < 0.01 ; 
*** p < 0.001 compared with values before the latest HS administration. 
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After the second administration of HS a further increase in 
sodium concentration to -160 mmol/1 from -150 mmol/1 was 
measured, while potassium remained mainly unchanged. The 
osmolality increased similarity in both groups reaching values of -350 
mOsm/kg. The sodium concentration and osmolality remained at this 
high level in the postischaemic period (E). 
Myocardial Functional and Metabolic Effects 
of Hypertonic Saline in Ischaemic Hearts 
Ischaemia plus Hypertonic Saline group 
CF in the ischaemic hearts was not influenced by hypertonic 
saline, (Figure 8, Table 3), while SV decreased transiently within 1 min 
( B  t o  B l  [ 1  m i n  a f t e r  t h e  i n i t i a l  a d m i n i s t r a t i o n  o f  H S ]  a n d  C  t o  C l  [ 1  
min after the second administration of HS]) after both HS 
administrations (p < 0.001). SV returned within 3 mins to the 
preinfusion value after the first infusion. However, after the second 
infusion SV remained significantly (p < 0.05) depressed for a long 
period of time (Figure 8, Table 3). HS was not found to have significantly 
influenced MVO2 and 02-extraction, (Figure 8, Table 3), or lactate efflux 
(Table 3). 
Myocardial Functional and Metabolic Effects 
of Hypertonic Saline in Nonischaemic Hearts 
Control-Hypertonic Saline group 
CF decreased significantly after both HS administrations within 
1 min (B to Bi [p < 0.0 01]; C to Ci [P < 0.01 ]; (Figure 8, Table 3). The 
reductions were transient, and CF returned to previous values within 3 
mins. SV decreased significantly (p < 0.001) after both HS 
administrations within 1 m in (B to B i; C to Cl; Figure 8, Table 3) and 
did not return to previous values within 3 mins (B to B3 [p < 0.0 5]; C 
to C3 [p < 0.01]). 
HS caused a transient decrease in MVO2 1 min after the first (B to B1 
[p < 0.001] ) as well as after the second HS administration (C to Ci [p < 
0.01]). However, MVO2 returned to the previous values within 3 mins 
(Figure 8, Table 3). 02-extraction decreased slightly but significantly 1 
min after the first HS administration (B to Bj [p < 0.01]). 
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The recovery to value before the administration of HS was somewhat 
slow and the difference between the pre-administration value and the 
value 3 mins after administration of HS was still significant (p < 0. 01), 
but in period C, 02-extraction had returned to its previous value 
(Figure 8, Table 3). After the second HS administration 02-extraction 
did not change significantly. HS was not found to influence the lactate 
efflux of the nonischaemic isolated heart (Table 3). 
Change in Percent over Time from Baseline Values 
Comparisons of myocardial function and metabolism over time 
(periods A vs E) in the three different experimental groups indicate 
significant reductions of SV in the HS groups (p < 0.001) with 24.4 % in 
the ischaemia plus hypertonic saline group and with 20.3 % in the 
control-hypertonic saline group. The reductions differed significantly (p < 
0.05) from the control-ischaemia group (7.8 %), while CF, O2-extraction, 
MVO2 and lactate efflux values did not differ between groups (Figure 9). 
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Figure 9. Percent change from baseline to end oj experiment of s troke volume 
(SV), coronary flow (CF), myocardial oxygen extraction (O2 Extr.), my ocardial 
oxygen consumption (MVO2), and cardiac lactate efflux (LA Efflux). Open bars, 
control hearts receiving ischaemia; lightly hatched bars, hearts receiving 
ischaemia and hypertonic saline, darkly hatched bars, control hearts receiving 
hypertonic saline. Values are mean ± SEM. * p < 0 .05 vs control animals 
receiving ischaemia. 
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Paper III 
This study was focused on the effects of hypertonic saline and 
hypertonic saline /dextran on central haemodynamics, leg blood flow, 
and skeletal muscle metabolism at reperfusion after subtotal bilateral 
limb ischaemia. 
Effects of Distal Aortic Occlusion 
Central haemodynamics 
The aortic occlusion resulted in a rapid initial increase of MAP (p 
< 0.0001) and SVR (p < 0 .001) while HR (p < 0 .0001) slowly increased 
overtime. The CVP (p < 0 .01), SVI (p < 0 .001), iliac back pressure (IBP) 
(p < 0.0001), and skin blood flow (SBF) (p < 0.0001) were reduced. 
Cardiac index was unchanged. 
Blood Chemistry 
Serum electrolytes, osmolality, haemoglobin, haematocrit, and 
total protein levels remained mainly unchanged (ns) although there was 
a slight increase of the serum potassium level (p < 0. 05). 
Acid base data showed a slightly increased pH level (p < 0.05), 
and reduced PaC02 (p < 0.05), Pa02 (p < 0 .05), and Ü2-saturation (p < 
0.05), while base excess remained mainly unchanged (ns). 
Skeletal Muscle Metabolism 
The skeletal muscle content of the high energy phosphagens ATP 
(p < 0.05) and CrP (p < 0.0001) was reduced and the lactate content 
increased (p < 0 .001) at 220 min of aortic occlusion. 
Between Groups Differences during distal aortic occlusion 
There were no significant differences in the overall response 
pattern to aortic occlusion between the different treatment groups 
although there were slightly lower levels of sodium and osmolality in 
the HS group vs the NS group (p<0.05). 
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Fluid Therapy, Reperfusion Characteristics, and 
Biochemical Alterations 
Central haemodynamics 
During the 5-min period of flu id infusion prior to aortic reflow, 
MAP increased significantly in the HS and HSD groups (p < 0.0 5) while 
no major change was seen in the NS group. The release of the aortic 
occlusion resulted in a reduction of MAP in all groups (p < 0.0 5). MAP 
remained lower in the NS t han in the HS and HSD groups (p < 0. 05-
0.01 vs NS) during the reperfusion period (Figure 10). 
The blood pressure in the iliac artery (IBP) increased at reflow in 
all groups with the most pronounced increase in the HS group (Figure 
10). 
HR was slightly reduced in the NS and HSD groups while HR 
increased (p < 0.05) in the HS group during the initial 5 min treatment 
period significantly (p < 0.01) vs the NS group. HR increased in all 
groups during reperfusion. 
CI increased (p < 0. 05) in the HS and HSD groups at the initial 
fluid infusion while the changes in SVI remained non-significant. 
Following reperfusion a drop of CI and SVI occurred in all groups. There 
were no significant differences between the groups in CI and SVI. 
CVP increased more in the HS and HSD groups (p < 0. 05) than in 
the NS group during the fluid infusion prior to aortic reflow (Figure 11). 
The thoracic fluid index (TFI) v alues increased (p < 0 ,05) in the 
NS group at 15 min after reperfusion and remained increased while in 
the HS and HSD groups TFI was significantly reduced throughout the 
whole reperfusion period (Figure 11). 
SVR was reduced immediately following reflow in all groups and 
during prolonged reflow no significant differences between the groups 
were demonstrable. 
Peripheral skin perfusion {Laser doppler) increased following 
reperfusion to values near preocclusion baseline levels in all groups. 
There was a calculated blood loss of about 4 ml/kg b.w. in all 
groups. Urine output remained at about 30 ml/h throughout the 
experimental period. There were no differences beween the groups in 
body weight changes during the experiment. 
50 Waagstein L.M. Small Volume Resuscitation 
NS 
HS 
HSD 
CT 
X 
E 
E 
Q~ 
< 
2  -20  
<  
-30 
REPERFUSION OCC 
40 
-20 0 20 40 60 80 100 120 140 160 180 
mm 
6 0 -
50-
^  40 Ol 
X 
5 30 
E 
^  2 0 -
m 
< 
occ REPERFUSION 
- 2 0  
20 0 20 40 60 80 100 120 140 160 180 
min 
Figure 10. Effects of fluid therapy on mean arterial pressure (MAP) and 
iliac artery blood pressure (IBP) prior to and after deflation of aortic balloon. 
#p < 0.05; ##p < 0.01 HS vs NS; *p < 0.05; **p < 0.01 HSD vs NS. 
OCC = occlusion; T = fluid treatment period. Values are mean ± S EM. 
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Figure 11. Effects of fluid therapy on central venous pressure (CVP) and 
thoracic fluid index (TFI) prior to and after deflation of aortic balloon. #p < 0.05; 
##p < 0.01; ###p < 0.001 HS vs NS; *p < 0.05; **p < 0.01; ***p < 0.001 HSD us 
NS. OCC = occlusion; T = fluid treatment period. Values are mean ± SEM. 
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Blood Chemistry 
Serum sodium remained unchanged in the NS group while the 
infusions of HS and HSD resulted in S-Na and S-Cl increments of 
about 10 mmol/1 (p < 0.05). The corresponding increase in serum 
osmolality in the HS and HSD groups was about 20 mOsm/kg (p < 
0.05). S-K increased in all groups in the post-ischaemic period (p < 
0.05). Haemoglobin and haematocrit increased in the NS group (p < 
0.05) while serum protein levels were reduced in the HS and HSD 
groups (p < 0.05) at 15 min following the initial fluid treatment and 
reflow. At 180 min no significant differences in haemoglobin, 
haematocrit or serum protein levels remained between the different 
groups. 
Acid-base values were only marginally altered during the 
experimental procedure. At 15 min following reflow pH was reduced by 
0.07-0.10 pH units and base excess values by about 3 mmol/1 in all 
groups. After 180 min of reflow the acid-base status had normalised in 
all groups and no inter-group differences were demonstrable. 
S keletal Muscle Metabolism 
A significant regain of high energy phosphagens (ATP+CrP) 15 
min after reflow was observed in the HS group (p < 0 .05). At 180 min 
after reperfusion no significant differences between the treatment 
groups remained (Figure 12). The initial reduction of the lactate content 
of skeletal muscle at 15 min was more pronounced (p < 0.05) in the 
HSD than in the HS and NS groups. Further reduction of the lactate 
levels were seen after 180 rnin in all treatment groups (Figure 12). 
Skeletal Muscle Water Content 
The water content of skeletal muscle was significantly increased 
(p < 0 .05) in the NS group at 180 min following reflow but not in the 
HS or HSD groups. 
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Figure 12. Regain of high energy phosphagens and wash out of lactate in 
skeletal muscle 15 min and ISO min following fluid treatmen t and reperfusion. 
Values are ± SEM. 
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Paper IV 
This study investigates if h ypertonic saline ± d extran is safe as 
volume loading fluid in hypovolaemic situations {sepsis, burns, and 
haemorrhage due to surgery or trauma) for individuals with depressed 
left ventricular function. The study is following up paper II, w here the 
direct effects of hypertonic saline on myocardial function and 
metabolism was investigated in isolated ischaemic and nonischaemic 
hearts. 
Randomization and Inclusion of the Animals 
In total 38 animals were randomized into the study (HS, n=12; 
HSD, n=13; NS, n=13). Three animals in the HSD group were excluded 
due to ventricular fibrillation resistant to defibrillation (at 15, 23, 23 
min after start of reperfusion) and one animal in the NS group due to 
basal signs of myocardial damage (high pre-occlusion Troponin-T value 
of 4.65 ßg/1). Another four animals developed ventricular fibrillation 
(HS, n=2 at 1 and 5 min following reperfusion; HSD, n= 1 at 5 min 
following onset of occlusion; NS, n= 1 at 30 min following onset of 
occlusion) but could all be successfully defibrillated within < 2 min 
without remaining circulatory disturbances and were therefore included 
in the data analysis. The presented data are based on 34 animals (HS, 
n= 12; HSD, n=10; NS, n=12). 
Effects of Catheterization, Preparative Procedures, and 
40-min of LAD Occlusion 
Blood chemistry variables were at 10 min after catheterization 
within the normal range for the pig in all groups and the 
haemodynamics did not differ significantly. After the preparative 
procedures and the 30 min period of stabilisation there were some 
changes of minor significance. 
Occlusion blood chemistry data 
There were only minor changes in serum electrolytes, osmolality, 
total protein, glucose, blood lactate, and haematocrit levels during the 
LAD occlusion period as well as for acid-base and oxygenation data. 
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Occlusion haemodynamic data 
The myocardial ischaemia caused by the LAD occlusion resulted 
in a general decrease in MAP, CI , SVI, LVSWI, LVP, and +dP/dt. HR 
increased in the HSD and NS groups, and decreased slightly in the HS. 
PCWP, LVEDP, and PVR increased in all groups. Between the three 
experimental groups there were no significant differences in the 
haemodynamic changes during the LAD occlusion. 
Effects of Volume Loading and Reperfusion 
Blood chemistry 
The 10-min period of infusion (from 5-min before to 5 min after 
release of occlusion) sodium increased significantly reaching 152 
mmol/1 (p < 0. 01) in the HS and HSD (p < 0 .001 HS and HSD vs NS) 
groups while in the NS group sodium remained unchanged. Chloride 
which increased in the HS and HSD groups (p < 0.0 01) was unchanged 
in the NS group (p < 0 .001 HS and HSD vs NS). N a+ and CI" remained 
significantly elevated in the HS and HSD groups (p < 0.001 vs NS) 
throughout the experiment until 240 min of reperfusion. Corresponding 
dilution-associated decreases of K+ and Ca++ were initial seen in the 
HS and HSD groups (p < 0.01-0.001 HS and HSD vs NS). At later 
stages after the reperfusion K+ increased in all groups to levels at about 
5 mmol/1. 
Osmolality increased significantly (p < 0 .01) by 22 mOsm/kg in 
both HS and HSD groups at the end of the volume loading and 
remained increased in comparison to the NS group (p < 0.001) 
throughout the 240 min reperfusion study period. 
Total protein (p < 0 .01-0.001 HS and HSD vs NS), bl ood glucose 
(ns HS and HSD vs NS), and haematocrit (p < 0 .05-0.001 HS and HSD 
vs NS) decreased in response to the initial volume loading in all groups 
but significantly more in the HS and HSD groups. After 240 min of 
reperfusion the decrease in total protein and haematocrit were still 
significant in the HS and HSD groups vs NS (p < 0.01). 
Blood lactate decreased significantly in all groups with no 
difference between the groups. 
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Acid base and oxygenation data 
The effects of volume loading and initial re perfusion on acid base 
and oxygenation data were only minor. In the HS and HSD groups pH 
(p < 0 .05 HS vs NS; 0.05-0.01 HSD vs NS), base excess (p < 0 .01 HSD 
vs NS), and avDÛ2 (p < 0.01 HS and HSD vs NS) values decreased 
somewhat while PaÖ2, SaC>2, SvC>2, and PaC02 remained mainly 
unchanged in all groups. At 240 min of reperfusion DO2 and VO2 were 
reduced in all groups as part of a general haemodynamic deterioration 
at that stage. Acid base values were at this stage still mainly 
unchanged at the preocclusion level. 
Haemodynamics 
No significant effects of the different treatment fluids on HR and 
RPP were observed. 
MAP and MPAP were in the HSD group initially increased vs the NS 
group {p < 0 .05, p < 0.01) and at 15 mins reperfusion the increase in 
MPAP was also significantly higher vs HS (p < 0.01). 
CVP and PCWP increased initially more in the HS and HSD groups 
than in the NS group (p < 0.001-0.05 vs NS), and CVP remained 
significantly elevated in the HS group vs NS throughout the 240 min 
reperfusion period. PCWP was significantly elevated in the HSD group 
during 90 mins (p < 0. 001-0.05), and in the HS group (p < 0.001-0.05) 
vs the NS group during 120 mins of the reperfusion period. 
Initially CI increased significantly vs NS in the HS and HSD groups (p < 
0.05), and SVI increased only in the HSD group (p < 0 .05-0.01 vs NS, 
and p< 0.05 vs HS). 
LVEDP increased initially more in the HS and HSD groups (p < 0 .05 vs 
NS). 
LVSWI was significantly increased at 30 and 60 mins of reperfusion in 
the HSD group vs HS (p < 0.05). 
+dP/dt was unchanged (HSD) or depressed (HS) (p < 0 .01-0.05 vs NS 
from 15 min to 120 min during the reperfusion period by the 
hyperosmolar fluid treatment. 
SVR and PVR were initially reduced by HS and HSD vs NS (p < 0.05). 
The duration of the volume expansion was more pronounced by 
HSD than by HS and NS infusion indicated by the LVSWI and LVEDP 
relationships. 
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Release of Serum Markers of Myocardial Necrosis and 
Ischaemia 
During the surgical procedure, the isolation of LAD, and LAD 
occlusion only minor changes of the serum levels of ASAT, CK, C KM B, 
and TNT occurred and blood lactate was slightly increased by about 0.6 
mmol/1. 
At 180 min following reflow after the LAD occlusion period the 
serum levels of these markers of myocardial damage were all elevated 
and remained increased throughout the studied 240 min period. In the 
HSD group the increase of ASAT was more pronounced (p < 0.05 vs NS 
and HS at 180 min reperfusion, p < 0.01 vs HS at 240 min reperfusion) 
than in the HS and NS groups but no differences in CK, C KM B. and 
TNT between the different groups were observed. 
Myocardial Muscle Metabolites 
No differences related to the fluid treatment strategy chosen were 
demonstrable in the tissue levels of high energy phosphagens in the 
ischaemic myocardium at the end of the experiment Figure 13. 
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Figure 13. Myocardial muscle metabolites. Adenosin e mon ophosphate (AMP), 
adenosine diphosphate (ADP), adenosine triphosphate (ATP), creatine 
phosphate (CrP), glucose, and lactate. 
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Area at Risk and Infarct Size Quantification 
The results of the infarct and risk area quantifications are given 
in Figure 14. The area at risk given as percentage of the left ventricle 
and the infarcted area, given as percentage of the area at risk, were in 
the HS group 32.4±2.9 % and 20.2±3.3 % respectively. The 
corresponding values for the HSD group were 26.9+3.4 % and 23.7±3.9 
%, and for the NS group 29.3±2.5 % and 22.7±4.3 %. The calculated 
infarcted areas in percentage of the left ventricle were for HS 6.1%, for 
HSD 6.6 %, and for NS 6.5 %. There were no significant differences in 
the quantified areas of myocardial injury between the experimental 
groups. 
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Figure 14. Area at risk and myocardial infarct size. Myocardial infarction in % 
ojarea at risk (INF %of AAR), myocardial infarction in % of left ventricle (INF % 
of LV), and area at risk in %of left ventricle (AAR of LV). 
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5 .  Methodolog ica l  and  
Exper imenta l  
Cons idera t ions  
Experimental Models 
The acute blood loss of 30% of estimated blood volume in the 
SHR in paper I, resulting in a MAP decrease from -175 to 43 mm Hg. 
The prehaemorrhagic MAP level of SHR in the present study was similar 
to that previously observed for anesthetized SHR57"59 indicating a 
representative state of hypertension at induction of haemorrhage. 
Because of the simultaneously increased mortality and decreased 
ability to maintain hyperglycaemia after haemorrhage in the SHR,57-60 
SHR was used for evaluation of the efficiency of hypertonic treatment. 
In paper II the aim was to study direct effects of hypertonic saline 
on the function of nonischaemic and ischaemic myocardium, perfusion, 
and metabolism. The model used was an isolated, anterogradely 
perfused, atrial paced working rat heart preparation. The pacing at 
constant heart rate and adjustment of pre- and afterload to 
predetermined levels makes the maintenance of standardized 
physiological conditions possible. This model allows assessment of the 
effects on myocardial function, perfusion, and metabolism at constant 
afterload, preload, and heart rate in rats after exposure to 
s t a n d a r d i z e d ,  l o w- f l o w ,  c a r d i a c  i s c h a e m i a . 4 9 ' 6 1  D u r i n g  t h e  
experimental procedure there was no deterioration in myocardial 
function. This is evidenced by the fact that the myocardial function and 
metabolism (stroke volume, coronary flow, 02-extraction, MVO2, and 
LA-efflux) of control hearts after exposure to ischaemia returned to 
initial baseline values at the end of the experiment (Figure 9). 
In order to study physiological events in acute limb ischaemia, 
an atraumatic model simulating the clinical situation is ideal. Many 
experimental models for acute limb ischaemia include extensive 
dissection or use of tourniquets causing local pressure and sometimes 
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also venous obstruction. The model used in paper III is a relatively 
atraumatic pig model for acute bilateral hind limb ischaemia, 
simulating acute aortic saddle embolism. This previously described 
experimental model for simulation of clinical acute aortic saddle 
embolism was considered to constitute a suitable model for assessing 
the influences of different fluid treatment regimens on the post-
ischaemic recovery of tissue perfusion and metabolism.51 
In paper TV an experimental porcine model of LAD occ lusion and 
reperfusion was chosen because of similar physiology to humans as 
well as lack of collateral coronary circulation.62-65 
The model was similar to that described by Hamburger et al,52 with the 
exception of the anaesthetic technique used. 
Anaesthesia and Treatment Fluids 
Anaesthesia (I, II ) 
Depending on the need of duration for anaesthesia a short-
acting barbiturate, pentobarbital was chosen in paper I and a more 
u l t r a - sh o r t - a c t ing  ba r b i t u r a t e ,  me tohex i t a l  i n  pap er  I I .  
Barbiturates as well as all general anaesthetic agents studied 
cause myocardial depression at concentrations that are clinically or 
experimentally useful. This is a result of both by decreasing Ca2+ influx 
across the plasma membrane and reduced calcium ion concentrations 
in the sarcoplasmatic reticulum.66-67 During pacing of Langendorff type 
isolated heart preparation, left ventricular mechanical performance and 
O2 consumption was not affected by pentobarbital. Pentobarbital 
treated hearts were also completely insensitive to three times increases 
of Ca2+ in the perfusate.68 The same is probably true also for 
metohexital and this agent is also rapidly eliminated . 
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Anaesthesia (III, TV) 
For induction of anaesthesia in paper III and IV we used the 
rapid-acting analgesic and dissociative anaesthetic agent, ketamine 
(Ketalar®), and the anaesthesia was maintained with the hypnotic 
agent methomidate (Hypnodil®) and the sedative agent azaperone 
(Stresnil®). 
Anaesthesia with Methomidate and Azaperone demonstrates a 
marked degree of cardiovascular stability during and after anaesthesia. 
The heart, and respiratory rate slow down, probably because of lowered 
oxygen needs (Janssen Pharmaceutica, Beerse, Belgien). 
Ketamine has successfully been used in cardiac surgery in 
pigs,65 and is perhaps the most widely and safety used drug in porcine 
studies. Ketamine has marked effects on the cardiovascular system. It 
stimulates the heart in a clinically normal subject, manifested as an 
increase in heart rate, mean arterial pressure and cardiac output. 
Theese are probably indirect effects caused by a combination of 
parasympathetic inhibition and sympathetic stimulation.69 Subjects 
with cardiac arrhythmias do not appear to be detrimentally affected, 
but extreme caution is recommended in those with diseased or 
traumatized myocardium due to a direct negative inotropic effect 
coupled with an increase in cardiac work. The peripheral vasopressor 
response is considered to be centrally mediated, and there is no 
reported increase in preload.69 71 The stimuatory effects could be 
attenuated by co-administration of benzodiazepines or other 
hypnotics,72'73 and with the combination of ketamine, methomidate, 
and azaperone there were no adverse effects seen in paper ///.74 These 
anaesthetic agents were therefore chosen in paper IV. The use of 
ketamine before clamping and unclamping of LAD w as used to reduce 
pain and stress and thereby maybe also the risk of ventricular 
fibrillation. 
Hamburger et al 52 reported that the common problem with 
ventricular arrhythmias requiring administration of a variety of 
antiarrhythmic drugs and/or extensive defibrillation during the 
occlusion or at reperfusion 75-78 could be reduced to -20% by ultra­
short acting thiobarbiturate anaesthetic, Thiamylal®.52 
The chosen anaesthetic technique in paper IV r esulted in a similar low 
frequency of severe arrhythmias of about 20% (18%) as reported by 
Hamburger et al52 indicating that the anaesthetic procedure was 
adequate for this experimental model. 
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Treatment Fluids (I, II) 
On the basis of the pathophysiological response of SHR to 
haemorrhage our hypothesis was that a glucose-osmotic support would 
be more beneficial for reversal of hyopvolaemia in primaiy hypertension 
than sodium ionic hypertonicity. Therefore the fluids chosen for the 
resuscitation treatment in paper I were hypertonic glucose (HG) and 
hypertonic saline (HS). A third fluid, normal (isotonic) saline, was used 
for testing if normal saline with equal sodium load as in HS is more 
beneficial than hype ros m ola r i tv per se. 
In the present study the usually recommended small-volume 
resuscitation of 4 ml/kg b.w was not given of H G and HS but instead 
4.5 ml/kg of b.w. This means that a slightly larger percentage of the 
shed blood volume was replaced than in other studies of hypertonic 
treatment of haemorrhage. This larger volume replacement was 
necessary due to the known poor tolerance of SHR to blood loss.57'58-60 
Since the effects of HS on ischaemia-induced cardiac 
dysfunction in resuscitation of shock are still not known in detail, HS 
was used in paper II. 3% of HS was the required concentration to 
increase Na+ in the perfusate to -150- and -160 mmol/1. In 
retrogradely perfused, nonworking, isolated rat hearts, HS has been 
reported to depress myocardial function by influencing contractility and 
relaxation rate.44 The importance of the sodium ion as compared to 
osmolality per se for the efficacy of hypertonic fluid therapy in shock 
has been documented. A high plasma sodium level seems essential for 
survival.31-32 
In the present study a two-step increase in the sodium 
concentration of the perfusate was carried out, allowing us to assess 
the effects of increasing sodium level on cardiac performance. Perfusate 
sodium levels of -150 mmol/1 were reached after the first and -160 
mmol/1 after the second addition of HS, i.e. sodium levels similar to 
those achieved when HS is used in experimental36'79 or clinical shock 
treatment.80'81 Therefore the ionic and osmolar changes reached at the 
myocardial cell level in the present study should be representative for in 
uiuo sit uations. 
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Treatment Fluids (III, IV) 
At reperfusion after hypovolaemia-shock induced tissue 
ischaemia caused by haemorrhage, sepsis, burns, surgery, and in 
revascularization of coronary arteries and other vessels, there is of 
importance to choose the therapy inclusively the resuscitation fluids 
with the thought to diminish the ischaemia-reperfusion injury. 
Therefore, HS with or without dextran were used in paper III (acute 
limb ischaemia-reperfusion) and paper IV (acute myocardial ischaemia-
reperfusion) as therapy fluids because of their properties. Dextran 70 
was included as oncotic component due to its specific effects on the 
rheological behaviour of blood.82'83 Furthermore, dextrans exert 
pharmacological effects on red cell aggregation, platelet function, 
plasma viscosity, and leukocyte-endothelial cell interactions.84-87 
Therefore, the combined effects of dextran, including its potential 
as a free radical scavenger, and HS, with its oedema reducing 
capacity,88 were considered of potential value for reduction of both limb 
tissue, and myocardial damage in the experimental models Dextran 70 
has been suggested to be the colloid of choice to combine with HS in 
the treatment of shock and ischaemia.16,19,21,34,35,89 studies 
comparing dextran and hydroxyethylstarch (HES) suggest that dextran 
is preferable due to its specific beneficial microcirculatory effects by 
which ischaemia-induced leukocyte-endothelial cell interaction is 
attenuated.90 Dextran 70 has also been suggested to exert specific 
beneficial effects at reperfusion.35,44,91 jn addition to enhanced free 
radical scavenging44 dextran will further enhance microcirculation by 
the attenuation of leucocyte-endothelial interactions.35'91 
The Role of the Infusion Rate 
It is usually considered that a rapid infusion of hypertonic 
solution is mandatory for an efficient mobilization of endogenous 
fluid.29 However, rapid administration of HS has been suggested to 
decrease the vascular perfusion pressure. An immediate and severe 
hypotension before cardiovascular improvement secondary to a decrease 
in systemic vascular resistance was seen after rapid administration of 
HS solution (HS 7.5%, 3 ml/kg infused intravenenously for 1 min).43 In 
these studies the infusion was very fast and Kien et al43 conclude that 
acute hypotension caused by rapid infusion of HS was not mediated by 
cardiac depression but by a decrease in total peripheral resistance. This 
was reported already in 1961 as a cholinergic-like effects of hypertonic 
solutions infused for 10 sees in amounts of 1 ml/kg b.w.8 (HS 5-8%, 
hypertonic glucose 50%, urea 12,5-50%). 
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In a shock study of intestinal ischaemia infusion of HS (1.7 and 10 
ml/kg/min) resulted in an immediate severe blood pressure decrease 
associated with cardiac arrythmias and/or breathing difficulties.42 In 
the SHR study (paper I) no hypotensive effect of HS was seen with a 
slow infusion rate (0.45 ml/kg/min) and arrythmias were only observed 
premortally similar to the other groups. An efficient initial increase in 
MAP and maintenance of i ncreased serum sodium at 30 and 90 min 
after treatment indicated a good volume supporting effect of the 
infusion rate used. Also in study III, and IV th e treatment fluids were 
given very slowly at a rate of 0.4 ml/kg/min. The increased serum 
sodium and osmolality, simultaneously with dilutional effects shown 
as reduction of serum potassium, and proteins as well as the 
haemodynamic response indicate that the infusion rate was effective. In 
paper II the HS of 3% was thrown into and mixed with the perfusate in 
a reservoir and in part into the 130 cm long chamber to reach ~ 150-
and -160 mmol/l Na+. 
Measurements of Central H ae m o d y n amies. 
Muscle  Metabol i tes ,  and Skin Blood Flow ( III )  
Transthoracic Electrical Bioimpedans (TEB) 
TEB was used in paper III for the cardiac output determination 
since Jivegård et al54 documented a close correlation in the pig between 
electrical bioimpedance and thermodilution measurements under 
varying experimental conditions. 
Muscle Metabolites 
The ATP, CrP, and lactate levels of skeletal muscle were used for 
the assessment of the metabolic alterations induced by the incomplete 
limb ischaemia. We have previously demonstrated significant 
relationships between alterations of these metabolite levels and the 
membrane function (transmembrane potential) of skeletal muscle cells 
during conditions of shock and ischaemia.92 
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Laser Doppler Flowmetry - LDF 
The laser Doppler flowmetry technique used for continuous 
monitoring of microvascular perfusion within tissues was described by 
Nilsson et al.93 Laser Doppler flow measurements provide a noninvasive 
evaluation of local skin blood flow and has previously been used in 
porcine and man studies,51'53 and the method was considered to be 
suitable for continuous measurements of skin blood flow in this study. 
Measurements of Area at Risk and Infarct Size 
( IV)  
TTC-Staming 
The TTC staining technique has previously been used in other 
studies and shown to adequately differentiate viable from non-viable 
myocardium in the area at risk after LAD occlusion. 52,75,76,94 jt jias 
been pointed out that the critical variable for the occurrence of 
significant myocardial damage is the period of coronary artery 
occlusion, and a 15 min period has been considered insufficient for 
infarction.75 The break point between significant and non-significant 
damage has been suggested to be at -45 min or longer.76 The 45 mins 
duration of LAD occlus ion chosen in the present study demonstrated a 
significant myocardial damage. 
Planimetrical Measurement 
A planimetrical method using the processing and analysis 
program, NIH Image 1,54 for the Macintosh has previously been used 
for measurements of in farcted areas and areas at risk.52 The method 
was used in our study and two individuals measured the areas 
independently. The correlation between the two observers showed 
coefficients of correlation for the measured areas of 0.91 for Area at 
risk, 0.97 for infarcted size of Area at risk, and 0.94 for infarct size of 
left ventricle. The mean values of the two observers measurements were 
used in the study. Theese procedures were considered adequate for 
measurement of the different areas. 
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6. General Discussion 
This thesis is based on four experimental studies in rats and 
pigs with focus on hypertonic-hyperoncotic volume loading with 
hypertonic glucose and hypertonic saline with or without dextran 70 
during a variety of conditions with impaired cardiac performance, 
depressed liver function and cardiovascular reserve. 
Although osmolality has been considered important in the 
etiology of shock,10-95 the essential role of sodium has also been 
documented.31'32 Experimental studies have demonstrated the 
importance of hyperosmotic resuscitation resulting from fluid 
mobilization to the intravascular compartment in particular after 
hypovolemia due to haemorrhage.29 HS has been reported to increase 
cardiac output6-14,25,36,96,79 as a result of a combination of increased 
cardiac contractility, plasma volume expansion, and peripheral 
vasodilation.97 However, these findings were demonstrated in subjects 
with normal cardiac function, studied in intact animals56 and 
hypovolemic shock.6-14,25,36.79,97 Questions have been arisen whether 
subjects with compromised cardiac function would react in a similar 
way, or be deleterious6 because of an increased oxygen consumption 
when HS exerts a positive chronotropic effect. 
Improvement of microvascular blood flow is necessary for reversal 
of the microcirculatory dysfunction caused by ischaemia and 
reperfusion.35 Hypertonic solutions may salvage the micro-circulation 
both by deswelling endothelial cells and corpuscular blood elements, 
and by inhibiting leucocyte adhesion to endothelial surfaces.29»98 Such 
effects are of importance for the integrity of the endothelial barrier 
function and thereby for the transfer of fluid from the vessels into the 
interstitial space in the reperfusion period.29-98 
Menger et al" investigated microvascular injury induced by 
ischaemia-reperfusion in striated muscle and they proposed that within 
the microvascular network three components contribute to ischaemla-
reperfusion (I/R) -induced reflow paradox, i.e., generation of oxygen 
radicals, release of chemoattractants, and adherence of leucocytes, 
which may induce lipid peroxidation, membrane disintegration, and 
loss of endothelial integrity, finally resulting in increased microvascular 
permeability, cell death, and tissue damage.99 
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After prolonged periods of ischaemia under nonisovolumetric 
conditions a patchy reperfusion occur when perfusion buffer is 
reintroduced to the coronary circulation. This is called the no-refiow 
phenomenon, and is due to capillary "shut down" and occurs not 
because of thrombosis but rather because osmotic swelling of the 
cardiac myocytes or tissue oedema that constricts the capillaries.100'101 
Hypertonic Fluids Administration after Haemorrhage in 
the SHR 
(paper I) 
A deficient glucose mobilization of SHR following haemorrhage 
has previously been reported60 and in accordance maximum glucose 
levels reached only ~8 -10 mmol/1 in paper I, as compared to -20 
mmol/1 in normotensive rats.60 The hyperglycaemic response was also 
of short duration in the present study with normo- to hypoglycaemic 
levels reached at 30 mins after haemorrhage in untreated control rats. 
Since the hyperglycaemic response to blood loss seems attenuated 
in SHR,60 HG was expected to be of particular benefit. With the small-
volume HG regimen, hyperglycaemia was prolonged in the present 
study, but still the haemodilutional effect of H G was less pronounced 
than that of HS. The greater volume-expanding effect from HS as 
compared to HG might be explained by a distribution of sodium ions 
mainly within the extracellular space, while glucose is also taken up 
and metabolized by tissue cells. The more pronounced haemodilution 
after HS than after HG treatment is considered to have contributed to 
increased venous return thereby increasing cardiac output and regional 
blood flow.34-102-104 
In particular splanchnic perfusion has been shown to improve in 
response to HS.97 This should be of specific value in the treatment of 
blood loss since liver perfusion is known to be critically reduced by 
hypotension105 and liver metabolic disturbances induced by 
haemorrhagic hypotension seem even more critical in hypertensive 
disease.57'58' The increased hepatic vulnerability in hypertensive 
disease is probably not due to disturbances in cellular function59 but 
rather to the presence of structural changes in hepatic and portal 
vessels.106-107 Reduced blood flow to the liver and thereby inadequate 
glycogenolysis and gluconeogenesis must, therefore, be the main 
explanation for the impaired glucose mobilization of SHR in response 
to haemorrhage and for the poor shock tolerance of SHR.57 60 It is 
surprising that the rather massive load of glucose did not induce any 
pronounced hyperglycaemia. The explanation could be that pancreas is 
still intact with capacity to produce insulin according to of the 
increased blood glucose. 
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The resuscitation with HG, thus, did not correct the disturbed 
glucose metabolism, but rather increased lactate production. Lactate 
levels, thus, increased more after HG than after HS or NS, a nd were of 
similar magnitude in this group as in untreated bled SHR. The present 
results therefore indicate a poorer improvement of the splanchnic 
perfusion in response to HG than to HS or NS treatment. 
Hyperosmolar solutions have been claimed to exert beneficial 
effects on cardiac performance.41 •96-97 In the treatment of shock in 
SHR, this may be of s pecific value since SHR seem to have a poorer 
cardiac performance than normotensive rats at low perfusion 
pressures.108 In addition, already in the basal state SHR have an 
increased sympathetic activity109-110 which together with venous 
structural changes107 could reduce the whole-body venous capacity.111" 
113 The remaining capacity of the venous system to maintain an 
adequate cardiac filling pressure after blood loss therefore seems 
limited.114 Reduced venous return and impaired cardiac performance 
thus seem to be critical factors for SHR after blood loss. Hypertonic 
glucose could then be expected to be beneficial, since it has been shown 
to improve ventricular function in nonischaemic as well as 
postischaemic hearts in normotensive rats while HS alone did not 
improve myocardial function.44 
Both HG and HS were found to exert positive chronotropic 
effects. The cardiostimulatory effect seemed more pronounced after HS 
than HG, since increase in arterial pressure was higher after HS. The 
higher MAP level a fter HS could be due to better transcapillary refill 
compared with HG which might in turn have improved cardiac 
performance. However, the MAP increase was more pronounced 
immediately after start of treatment, indicating a possible direct 
cardiostimulatory effect or more generalized effects of an enhanced 
sympathetic activity by HS. 
Cerebroventricular administration of HS is known to enhance 
sympathetic activity.115 The cardiovascular changes observed after 
intravenous small-volume resuscitation with 2400 mOsm/1 HS during 
severe haemorrhagic shock6-14 are similar to those induced by 
intraventricular infusion of HS.116 Increased sodium levels of -15-20 
mmol/1 in the cerebrospinal fluid, which are levels comparable to those 
reached in plasma after standard HS treatment, have been shown to 
improve cardiovascular function and increase the tolerance to 
hemorrhage.116 The observed beneficial effects of HS on cardiovascular 
performance after hemorrhage in the present study could therefore be 
mainly due to activation of cerebral sodium sensors rather than to 
direct cardiostimulatory effects. 
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Ns seemed as effective as HS for resuscitation of haemorrhage in 
SHR, The major disadvantage of NS r esuscitation is the large volume 
requirements which include a risk of oedema formation. Oedema 
generally appears after haemorrhagic shock, but different opinions have 
been presented concerning the distribution of extravascular fluid. 
Calculations of the cellular fluid content based on membrane potential 
measurements117 and direct microvascular observations35 suggest that 
circulatory shock rapidly causes cellular oedema in heart, muscle and 
endothelial cells. On the other hand, distribution of t racers suggests 
that an increase in intracellular water content does not always occur 
after shock, but interstitial expansion will usually follow fluid 
resuscitation therapy.118 The hypovolaemia reversing effects obtained 
with NS in paper I we re comparable to or even better than those of HS 
in spite of the fact that a volume of only 2.1 times the shed blood 
volume was infused. The fact that both treatments included the same 
amount of sodium ions and were comparable in efficiency for 
resuscitation point to the importance of sodium for maintenance of 
blood volume and extracellular fluid. 
The good survival of NS treated SHR emphasizes the importance 
of adequate volume loading for successful treatment of acute 
haemorrhage. The hypertonic fluid regimens used in the present study 
should consequently either include colloid or be followed by additional 
fluid infusion to achieve optimal posthaemorrhagic survival because 
the effect of small-volume hypertonic solutions is short-lived.119 
HS and Ischaemia-Reperfusion in Vitro 
(paper II) 
In the study of isolated, antegradely perfused, working rat heart 
no direct positive inotropic effect of hypertonic saline on myocardial 
function could be demonstrated. Both additions of HS to the 
nonischaemic as well as to the ischaemic isolated heart caused 
consistent, transient depressions of cardiac performance, as shown by 
reduction of stroke volume lasting for ~3 mins. Since the hearts were 
paced at a constant heart rate and kept on constant preload and 
afterload, the observed reduction in stroke volume is due to depressed 
contractility. Similar depression of ventricular function by HS in a 
nonischaemic and postischaemic isolated, retrogradely perfused 
nonworking Langendorff heart preparation has been reported by Brown 
et al.44 The present study indicates that HS may enhance the 
functional detoriation of the isolated heart preparation, since 
nonischaemic as well as ischaemic hearts exposed to HS were found to 
maintain a poor stroke volume over time when compared with control 
hearts exposed to ischaemia only (Figure 9). 
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Shock resuscitation with hyperosmolar solutions is usually 
reported to be beneficial due to improved cardiac output and tissue 
perfusion.6'14'25'36-79-96 Results from studies6'14-40-41 of i ntact animals 
have suggested that myocardial contractility may be increased by 
hypertonic saline. In isolated cardiac tissue a negative inotropic effect 
of increased sodium concentration was previously reported by Bassini 
et al120 and Tillisch and Langer.121 Part of the myocardial depressant 
effects of hypertonic saline may be due to loss of water from the muscle 
fibers.122 Thus, extracellular as well as intracellular sodium 
concentrations are increased i.e., changes in concentration gradient are 
induced that are associated with decreased myocardial contractility.123  
An increased ratio of the internal /external sodium activities may lead 
to a decrease in intracellular calcium activity via sodium-calcium 
exchange and thereby a negative inotropic effects.123 
The myocardial metabolic effects of HS administration were only 
seen in the nonischaemic heart and as transiently reduced myocardial 
oxygen consumption. A concomitant decrease in coronary flow caused 
by autoregulation maintained the myocardial oxygen extraction at a 
constant rate. 
The observations of a myocardial-depressant effect of HS on the 
isolated nonischaemic and ischaemic working rat heart in paper II 
favour the concept that the reported stimulatory effects of HS on 
myocardial performance in shock resuscitation must be mainly indirect 
through central mechanisms. Infusion of hypertonic saline has been 
shown transiently to increase plasma catecholamine levels.124 Liang 
and Hood40 considered this result to be at least in part responsible for 
the inotropic action of hypertonic saline. The observation of increases 
in intracerebroventricular or intracerebral sodium concentration 
similar to those in blood after hypertonic saline resuscitation116 could 
indicate that activation of central cerebral mechanisms may be 
important. Activation of a pulmonary reflex was originally suggested by 
Rocha-e-Silva et al,104 although the contribution of such a reflex to 
the beneficial haemodynamic effects of hypertonic saline in shock 
resuscitation has been questioned.125 Attenuation of the plasma 
activity of a myocardial-depressant factor has been another suggested 
beneficial effect of hypertonic saline.37 Since no direct positive 
inotropic effect could be demonstrated from HS in isolated hearts, the 
cardiostimulatoiy effect and efficiency of HS resuscitation seems to be 
mainly due to central sympathetic activation. 
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Hypertonic-Hyperoncotic Fluids Administration in Lower 
Limb Ischaemia-Reperfusion in the Pig 
(paper III) 
In vascular surgery it is well known that acute non-traumatic 
lower limb ischaemia is associated with high mortality rates, often 
exceeding 25%.126 It is possible that the high mortality rates in 
connection with acute limb ischaemia could be reduced if the surgical 
treatment is combined with intravascular fluid regimens that more 
rapidly and efficiently improve tissue perfusion by enhancing 
microvascular blood flow, reducing blood cell-endothelial cell 
interactions, and diminishing tissue oedema formation following 
reflow. 
It has previously been shown that the aortic occlusion reduces 
the blood flow in the femoral vein from about 125 ml/min to 4 ml/min 
reducing correspondingly tissue oxygen tension.51 The demonstrated 
increase in skeletal muscle lactate content and reduction of h igh energy 
phosphagens during the 4 h period of incomplete ischaemia in paper III 
therefore clearly indicate reduced regional tissue oxygen availability and 
partly anaerobic cellular metabolism.92-127128 Systemic derangements 
of the acid-base balance during the period of incomplete limb ischaemia 
were not observed indicating that the systemic effects of the local 
hypoxic events were centrally compensated. 
During infusion of the different fluids prior to the deflation of the 
aortic balloon a more efficient blood volume expanding effect was 
obtained with HS and HSD than with NS, as shown by the changes in 
C VP, MAP and TFI. TFI was in this study assumed mainly to reflect the 
central venous return. Reflow following complete as well as incomplete 
limb ischaemia is consistently accompanied by hypotension as observed 
in the present study. Following reflow this initial central 
haemodynamic deterioration was less pronounced in the HS and HSD 
groups than in the NS group. It has previously been documented that 
the infusion of a hypertonic solution results in a dynamic fluid 
redistribution from extravascular sources into the vascular 
compartment.29 Such a fluid mobilization may not be expected at the 
infusion of 4 ml /kg of NS wh ich clearly is a suboptimal fluid volume. 
Also the volume expanding effect of HS per se is transient and of 
relatively short duration due to a redistribution back into the 
extravascular sources.29 Therefore the use of HS in combination with a 
colloid is usually advocated since haemodynamic stability thereby will 
be maintained for a more prolonged period of t ime.2116 In the present 
study MAP was also better maintained over time in the post-ischaemic 
period in the HSD than in the HS and NS groups. 
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The microcirculation through the capillaries has been reported to 
be restituted more efficiently by hyperosmotic-hyperoncotic 
solutions34-35 resulting in improved tissue nutrition.The somewhat 
better clearance of lactate from skeletal muscle and more rapid 
restitution of the high energy phosphagen levels in the HSD group 
favour such a concept. 
The role of leukocytes in the pathophysiology of skeletal muscle 
ischaemic injury has been well documented99'129 and leukocyte 
depletion has been shown to attenuate post-ischaemic vascular 
injury.130 Dextran may not only modulate the endothelial surface 
charge of capillaries but also reduce endothelial permeability.86 A 
dextran related reduced access of different molecules to the cell surface 
by steric hindrance and/or electrostatic shielding of t he glycolyx may 
explain such effects.86 Consequently dextran seems to modulate several 
of the pathophysiological events that occur in the post-ischaemic reflow 
period, i.e. events related to "no-reflow" phenomena (white blood cell 
plugging of capillaries), release of inflammatory mediators, and 
formation of oxygen-derived free radicals. Such beneficial effects of 
dextran in combination with hypertonic saline on microvascular blood 
flow in the post-ischaemic period are indicated in the present study by 
the more efficient metabolic restitution of the ischaemia-induced 
metabolic disturbances in skeletal muscle in the HSD group. 
Tissue oedema formation at reflow in the post-ischaemic period 
is considered a factor influencing microvascular blood flow and tissue 
oxygen supply. It has recently been shown that hypertonic-hyperoncotic 
fluid treatment will efficiently mobilize oedema induced by hydrostatic 
factors or inflammatory mediators such as bradykinin.88 Vascular 
ischaemia, as seen in connection with peripheral vascular or major 
aortic vascular surgery is often associated with post-ischaemic fluid 
retention and oedema formation. In connection with aortic surgery 
quite often major body weight changes of up to 7-8% have been 
noted.131 By the use of hypertonic intravenous fluids during aortic 
surgery it has been shown that haemodynamic stability can be well 
maintained at less volume transfusion.131132 Thereby the risk of fluid 
overload and extensive increase in body weight may be prevented. 
Intraoperative combined use of hyperosmotic/hyperoncotic solutions 
may be even more advantageous to avoidance of tissue fluid 
accumulation.133 Our observations of enhanced post-ischaemic 
metabolic recovery in the 7,5% HS 6% dextran 70 group indicate that 
even a low colloid content seems to enhance the post-ischaemic tissue 
metabolic recovery but a higher colloid concentration could be even 
more effective.119 
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Hypertonic-Hyperoncotic Fluids Administration in 
Myocardial Infarction-Reperfusion in the Pig 
(paper IV) 
Experimental and clinical studies in severe haemorrhagic shock 
have shown beneficial effects of small volume of HS -7.5% with or 
without colloid on cardiovascular performance.6,14,19,21,25,31,36,37,39 
In trauma victims with already impaired left ventricular function 
there is a high risk for development of either transient cardiac 
ischaemia or acute myocardial infarction due to hypotension after 
major haemorrhage and causing hypoperfusion of the myocardium. The 
value of resuscitation fluid is important and may prevent myocardial 
ischaemia. In patients with right ventricular infarction the preload 
increase after fluid loading is important as shown in cardiogenic shock 
due to right ventricular infarction80 whereas in patients with left 
ventricular infarction volume loading can cause left ventricular failure. 
The effects of HS/HSD therapy of shock in patients with depressed left 
ventricular function have not been investigated so far. 
The effects of hypertonic solutions on the left ventricle 
performance have been studied in cardiac tissues samples, in isolated 
heart preparations, and in different experimental and clinical settings 
but the functional role of such treatment has still not been 
conclusively clarified. 10,40,41,43-45,80,97,120,134-137 when HS is 
administered in the treatment of haemorrhagic shock the left ventricle 
is usually not compromised due to myocardial injury and the left 
ventricle is capable to react normally if pre load can be increased. This 
may explain the reported beneficial cardiovascular effects of HS or HSD 
in the treatment of haemorrhagic hypotension,614'39 
In paper IV t he effects of hypertonic saline±dextran 70 in left 
ventricular myocardial infarction and reperfusion were investigated. The 
occlusion of LAD d uring a 45 min period and thereafter a 240 min 
period of reperfusion allowed us to study the animals during a longer 
period and recording haemodynamic and metabolic effects of HS and 
HSD and development of the myocardial insult after induced left 
ventricular ischaemia and reperfusion. 
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The infusion of HS and HSD resulted in expected increases of 
serum Na+ and osmolality. The haemodilutional blood volume 
expansion was evidenced by reduced K+, Ca++, plasma protein levels, 
and haematocrit readings. The fluid mobilization induced by HS and 
HSD was furthermore reflected by increased right and left ventricular 
filling pressures. The positive haemodynamic effects initially induced by 
HS and HSD were mainly seen as increased CI at the end of the 
infusion but the changes were of short duration, especially for HS. The 
combination of HS and dextran increased cardiac performance as 
opposed to HS alone due to the colloid osmotic effects and prolonged 
intravascular persistence of dextran 70.83 
Volume loading by HS or HSD infusion may further increase an 
already increased preload of the failing ischaemic left ventricle. This 
could explain that myocardial contractility (+dP/dt) was not found to 
be enhanced but instead significantly decreased in the HS treated 
animals at 10 mins after the end of the infusion. However, even if CVP 
and PCWP were enhanced by HS and HSD administration in the 
present study, they did not reach that levels seen in heart failure. 
When plotting Frank-Starling curves {left ventricular stroke work index 
(LVSW1) versus left ventricular end-diastolic pressure (LVEDP) HS 
treatment was found to cause a prolonged functional depression, while 
functional depression after HSD treatment was not obvious until 
towards the end of the reperfusion perlod. Such differences could reflect 
the beneficial influences of dextran, as a free radical scavenger and 
promotor of capillary blood flow, on myocardial performance in the 
post-ischaemic period. This would be in agreement with the suggestion 
of Brown et al44 that the post-shock benefit of HSD is unrelated to 
direct myocardial effects of saline but rather to toxic oxygen metabolite 
scavenging by dextran. 
In the treatment of cardiogenic shock due to right ventricular 
infarction80 volume expansion will increase preload in the right 
ventricle necessary for the falling ventricle to produce an adequate 
stroke volume. In such a situation volume loading with hypertonic 
solution is important for normalizing left ventricular preload. When, on 
the other hand as in the present study, the left ventricle is damaged by 
an infarct the situation is quite different. 
The initial change of heart rate (HR) was found to be small in all 
groups at the reperfusion in the present study. This is in contrast to 
the findings of other studies reporting increased HR in response to 
treatment with HS.41 The lack of major HR changes in response to 
treatment could reflect an already high sympathetic tone caused by the 
acute myocardial infarction138 or an high vagal tone. 
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Since HR did not differ among the three experimental groups, HR could 
probably not be a determinant parameter explaining the difference in 
contractility state between the groups. 
In paper II we found that repeated additions of HS to 
nonischaemic as well as to ischaemic, isolated, anterogradely perfused, 
working rat hearts caused transient depressions of cardiac performance 
following each HS administration.45 Since HR was paced at a constant 
rate and at unchanged left atrial pressure in that experimental model 
the observed reduction in stroke volume was assumed mainly to reflect 
direct negative inotropic myocardial effects. Depressant rather than 
stimulatory effects of HS on myocardial performance has been indicated 
also in other experimental studies.44'135 The cardio-depressant effect 
has been claimed to be due to large HS doses or very fast infusion 
rates.4-43 In the present study the commonly used dose of 4 ml/kg b.w. 
was infused over a period of 10 min which is supposed to be a slow 
infusion. In a recently published study of HS infusion by Kien et al,139  
the contractile function and blood flow were investigated in regions of 
normal myocardium and ischaemic myocardium after occlusion of LAD. 
The authors found that contractile function and blood flow were 
improved in the normal myocardium after HS infusion but decreased in 
the region distal to coronary occlusion (ischaemic myocardium) and 
that this could lead to worsening of i schaemic injury. They concluded 
that HS may be deleterious in hearts with impaired contractile function 
caused by ischaemia and also that additional studies are warranted to 
investigate the safety of HS in patients with impaired myocardial 
function due to coronary vascular disease. 
In our study the measured area of infarct size and area at risk 
did not differ between the groups and thereby was not the ischaemic 
injury worsened by HS and HSD compared to normal saline infusion at 
reperfusion after LAD occlusion (Figure 14). Although HS/HSD has 
previously been suggested to exert beneficial effects on outcome when 
used for resuscitation of shock and hypovolemia14'19'21'25 29.31.36,37,39 
no reduction of the myocardial ischaemic insult could be demonstrated 
in the present study. There were no differences seen between the groups 
regarding myocardial metabolites at the end of the reperfusion period 
(Figure 13). The release of serum markers of myocardial damage did not 
differ with the exception of ASAT w hich in the reperfusion period was 
significantly more increased in the HSD group compared to NS and HS. 
This could possibly reflect a better washout from the ischaemic area 
resultant from the positive microcirculatory effects of dextran. 
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Potential Clinical Use of Hypertonic-Hyperoncotic 
Therapy with HSD in Patients with Depressed or 
Infarcted Left Ventricle. 
In elderly patients undergoing surgical procedures coronary artery 
disease is often present also in the asymptomatic patients and 
asymptomatic left ventricular dysfunction may also be present. In case 
of major haemorrhage causing hypovolaemia these patients are at risk 
developing myocardial infarction peroperatively. 
Hypertonic saline-6% hydroxyethyl starch has been used 
effectively for preoperatve hemodilution in cardiac surgery in patients 
with coronary artery disease,139 and is also found effective for 
postoperative fluid replacement in patients after cardiac 
revascularization.140 Administration of HS with or without colloid as 
fluid replacement during reconstructive vascular surgery has not been 
investigated and consequently a need to clarify if the use of these fluids 
could worsen an ischaemic and postischaemic stunning. 
In patients undergoing revascularization with percutaneous 
transluminal coronary angioplasty (PTCA) after acute myocardial 
infarction the use of high doses of thrombolytic agents, for example 
heparin, could cause major haemorrhages. Instead of, or in 
combination with a more moderate dosage of the used thrombolytic 
agent, administration of hypertonic saline-dextran 70 may be of value, 
due to its oedema reducing capacity88 and positive rheological 
effects82'83 on red cell aggregation, platelet function, plasma viscosity, 
and leucocyte-endothelial cell interactions.84"87>91 Dextran 70 has also 
been suggested to exert specific beneficial effects at reperfusion,35'44'91 
and in addition to enhance free radical scavenging,44 which is a merit 
since it is known that oxygen free radicals can increase the expression 
of leucocyte adhesion molecules on endothelial wall.141'142 
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7. Conclusions 
I Hypertonic (2400 mOsm/1) glucose was less favourable than 
hypertonic saline for resuscitation after blood loss in the 
spontaneously hypertensive rat, due to less pronounced intra­
vascular volume expanding and arterial pressure supporting effects 
resulting in increased lactate load. In this experimental model 
the sodium load therefore seemed more beneficial than the hyper­
osmolar^ per se. However, adequate restitution of the lost fluid 
volume seems even more important for survival since about twice 
the bled volume given as isotonic 0.9% saline was found to be more 
effective than the same sodium load given as 7.5% NaCl solution. 
n The present results on an isolated paced, working rat heart 
preparation at controlled preload and afterload show that 
hypertonic saline exerts rapid transient as well as more 
prolonged myocardial depressive effects both under ischaemic 
and nonischaemic conditions. 
These observations indicate that the beneficial haemodynamic 
effects of hypertonic saline in shock treatment must be mediated 
mainly via systemic rather than direct myocardial mechanisms. 
III On the basis of the present study it is concluded that the infusion 
of small volumes (4 ml/kg of body weight) of hypertonic saline 6% 
dextran 70 at the time of tissue reperfusion following prolonged 
subtotal tissue ischaemia constitutes an efficient fluid regimen 
for reversal of ischaemia-induced haemodynamic and tissue 
metabolic disturbances. 
IV The infusion of hypertonic saline at reperfusion after 45 mins of 
myocardial ischaemia caused by LAD occlusion did not effectively 
improve haemodynamics or myocardial contractility and did not 
reduce or increase the myocardial damage in the post-ischaemic 
period. The combination of hypertonic saline and dextran 70 
seemed to be more effective for improving the haemodynamics and 
myocardial contractility, but neither reduction or increase of 
infarct size or area at risk could be demonstrated. 
Therefore, the present data do not clearly demonstrate that 
hypertonic saline treatment is of value for reduction of ischaemia 
induced acute myocardial damage. 
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